{
  "Status Epilepticus": {
    "id": "status-epilepticus",
    "title": "Status Epilepticus",
    "version": "1.4",
    "icd10": [
      "** G40.901 (Epilepsy",
      "unspecified",
      "not intractable",
      "with status epilepticus)",
      "G41.0 (Grand mal status epilepticus)",
      "G41.1 (Petit mal status epilepticus)",
      "G41.2 (Complex partial status epilepticus)",
      "G41.8 (Other status epilepticus)",
      "G41.9 (Status epilepticus",
      "unspecified)"
    ],
    "scope": "** Management of convulsive status epilepticus (CSE) and non-convulsive status epilepticus (NCSE) in adults. Covers staged treatment protocol from emergent benzodiazepines through refractory and super-refractory phases. Includes diagnostic workup to identify underlying etiology and specific protocols for NORSE/FIRES. Excludes pediatric status epilepticus, neonatal seizures, and psychogenic non-epileptic status.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities, renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Ionized 4.5-5.3 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, oxygenation, ventilation status",
            "target": "pH >7.2; correct severe acidosis",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated in prolonged seizure; marker of severity",
            "target": "Will be elevated; trending useful",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs, withdrawal states",
            "target": "Identify triggers",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol withdrawal common cause",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ASM levels (if on therapy)",
            "rationale": "Subtherapeutic levels as precipitant",
            "target": "Therapeutic range",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pregnancy test (women of childbearing age)",
            "rationale": "Eclampsia; affects ASM choice",
            "target": "Document status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, valproate toxicity, urea cycle disorders",
            "target": "<35 μmol/L",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid storm/myxedema",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac stress from prolonged seizure",
            "target": "May be elevated",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CPK/CK",
            "rationale": "Rhabdomyolysis from prolonged convulsions",
            "target": "Elevated; monitor trend",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cortisol (random)",
            "rationale": "Adrenal insufficiency",
            "target": "Normal stress response",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Procalcitonin",
            "rationale": "CNS infection if suspected",
            "target": "<0.5 ng/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Coagulation panel (PT/INR, PTT)",
            "rationale": "Pre-LP, hemorrhage risk",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Type and screen",
            "rationale": "Anticipate possible surgical intervention",
            "target": "Available",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as precipitant (especially elderly)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2 in NORSE",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking history, weight loss",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Mitochondrial DNA testing",
            "rationale": "MELAS, other mitochondrial disorders",
            "target": "Normal",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Pyridoxine trial (empiric)",
            "rationale": "Pyridoxine-dependent seizures (rare, usually pediatric)",
            "target": "Response to treatment",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "NORSE, limbic encephalitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "Demyelinating disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediately after stabilization",
            "target": "Mass, hemorrhage, stroke, herniation, hydrocephalus",
            "contraindications": "None in emergency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "As soon as available; mandatory in RSE/SRSE",
            "target": "Seizure burden, treatment response, NCSE detection",
            "contraindications": "None significant",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk, ETT placement confirmation",
            "target": "Aspiration, ETT position",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with and without contrast",
            "timing": "When stable; within 24-48h",
            "target": "Encephalitis, stroke, tumor, cortical injury from SE",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "CT angiography head/neck",
            "timing": "If stroke suspected",
            "target": "Large vessel occlusion, dissection",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "Venous thrombosis, vascular malformation",
            "contraindications": "Hemodynamic instability, pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "If paraneoplastic suspected",
            "target": "Occult malignancy",
            "contraindications": "Contrast allergy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected, endocarditis",
            "target": "Vegetation, thrombus",
            "contraindications": "None",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT (whole body)",
            "timing": "Occult malignancy workup",
            "target": "Tumor identification",
            "contraindications": "Hemodynamic instability",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Brain biopsy",
            "timing": "Refractory cases, suspected encephalitis",
            "target": "Histopathologic diagnosis",
            "contraindications": "Coagulopathy, critical location",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "—",
            "ICU": "EXT"
          }
        ]
      },
      "Treatment": {
        "Stabilization (Time 0)": [
          {
            "item": "Airway positioning/management",
            "dosing": {
              "instructions": "Head-tilt chin-lift, oral airway, prepare for intubation",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "O2 sat, airway patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "dosing": {
              "instructions": "Non-rebreather 15 L/min or bag-valve-mask",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV access (two large-bore)",
            "dosing": {
              "instructions": "18G or larger x2",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "IV patency",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Cardiac monitoring",
            "dosing": {
              "instructions": "Continuous telemetry",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Rhythm, HR, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50% IV",
            "dosing": {
              "instructions": "50 mL IV push (25g) if glucose <70 or unknown",
              "orderSentence": null
            },
            "contraindications": "Document hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine IV",
            "dosing": {
              "instructions": "100-500 mg IV BEFORE or WITH glucose",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Isotonic fluids",
            "dosing": {
              "instructions": "NS or LR wide open initially",
              "orderSentence": null
            },
            "contraindications": "Pulmonary edema",
            "monitoring": "BP, I/O",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Emergent/First-Line - Benzodiazepines (Time 0-5 min)": [
          {
            "item": "Lorazepam IV",
            "dosing": {
              "instructions": "0.1 mg/kg IV (max 4 mg/dose); may repeat x1 in 5 min if still seizing; total max 8 mg",
              "orderSentence": null
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP, sedation; airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM",
            "dosing": {
              "instructions": "10 mg IM (≥40 kg) or 0.2 mg/kg IM (if no IV access); single dose",
              "orderSentence": null
            },
            "contraindications": "Respiratory compromise",
            "monitoring": "RR, O2 sat; prepare IV access",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IV",
            "dosing": {
              "instructions": "0.2 mg/kg IV (max 10 mg); may repeat x1",
              "orderSentence": null
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat, BP",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal",
            "dosing": {
              "instructions": "5 mg per nostril (10 mg total) if no IV/IM access",
              "orderSentence": null
            },
            "contraindications": "Nasal obstruction",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam buccal",
            "dosing": {
              "instructions": "10 mg buccal (if available)",
              "orderSentence": null
            },
            "contraindications": "Oral trauma",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam IV",
            "dosing": {
              "instructions": "0.15 mg/kg IV (max 10 mg); may repeat x1 in 5 min",
              "orderSentence": null
            },
            "contraindications": "Acute narrow-angle glaucoma",
            "monitoring": "RR, O2 sat; short duration - requires follow-up ASM",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Diazepam rectal",
            "dosing": {
              "instructions": "0.2-0.5 mg/kg PR (max 20 mg); use rectal gel formulation",
              "orderSentence": null
            },
            "contraindications": "Rectal pathology",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Urgent/Second-Line ASMs (Time 5-20 min)": [
          {
            "item": "Levetiracetam IV (ESETT dosing)",
            "dosing": {
              "instructions": "60 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": null
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam IV (conservative)",
            "dosing": {
              "instructions": "40 mg/kg IV (max 4500 mg) over 10-15 min",
              "orderSentence": null
            },
            "contraindications": "None absolute; reduce if CrCl <50",
            "monitoring": "Generally well tolerated; agitation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fosphenytoin IV",
            "dosing": {
              "instructions": "20 mg PE/kg IV at 150 mg PE/min; may give additional 5-10 mg PE/kg if needed",
              "orderSentence": null
            },
            "contraindications": "2nd/3rd degree AV block, sinus bradycardia, allergy",
            "monitoring": "Continuous cardiac monitor, BP q5min during infusion",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "dosing": {
              "instructions": "40 mg/kg IV (max 3000 mg) over 10 min",
              "orderSentence": null
            },
            "contraindications": "Pregnancy, hepatic disease, mitochondrial disease, urea cycle disorders, pancreatitis",
            "monitoring": "Ammonia, LFTs; avoid in unknown pregnancy status",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "dosing": {
              "instructions": "400 mg IV over 15 min (can give 200 mg over 5 min if urgent)",
              "orderSentence": null
            },
            "contraindications": "PR >200 ms, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG for PR interval",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Brivaracetam IV",
            "dosing": {
              "instructions": "100-200 mg IV over 2-5 min; no titration needed",
              "orderSentence": null
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Faster onset than levetiracetam; fewer behavioral effects",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "dosing": {
              "instructions": "20 mg/kg IV at max 50 mg/min (if fosphenytoin unavailable)",
              "orderSentence": null
            },
            "contraindications": "AV block, sinus bradycardia",
            "monitoring": "Cardiac monitor; MUST use large vein, tissue necrosis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenobarbital IV",
            "dosing": {
              "instructions": "15-20 mg/kg IV at 50-100 mg/min",
              "orderSentence": null
            },
            "contraindications": "Severe respiratory disease, porphyria",
            "monitoring": "Respiratory depression; often requires intubation at this dose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Refractory SE - Anesthetic Infusions (Time 20-60 min)": [
          {
            "item": "Midazolam infusion",
            "dosing": {
              "instructions": "Load: 0.2 mg/kg IV bolus; Infusion: start 0.1 mg/kg/hr, titrate by 0.1 mg/kg/hr q15min to seizure suppression; max 2 mg/kg/hr; target burst suppression on cEEG",
              "orderSentence": null
            },
            "contraindications": "Hemodynamic instability (relative)",
            "monitoring": "cEEG, BP (hypotension common), sedation scale",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Propofol infusion",
            "dosing": {
              "instructions": "Load: 1-2 mg/kg IV bolus (may repeat x1); Infusion: start 20 mcg/kg/min, titrate by 10 mcg/kg/min q5min; max 200 mcg/kg/min; target burst suppression",
              "orderSentence": null
            },
            "contraindications": "Propofol infusion syndrome risk (limit to <48h at high dose), egg/soy allergy, pregnancy",
            "monitoring": "cEEG, triglycerides q24-48h, CPK, metabolic acidosis, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine infusion",
            "dosing": {
              "instructions": "Load: 1-2 mg/kg IV bolus; Infusion: start 1 mg/kg/hr, titrate by 0.5 mg/kg/hr q15-30min; max 5 mg/kg/hr",
              "orderSentence": null
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative - actually may be neuroprotective)",
            "monitoring": "cEEG, BP (may increase), HR; less hypotension than other anesthetics",
            "ED": "URGENT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Ketamine + Midazolam (combination)",
            "dosing": {
              "instructions": "Ketamine load 1 mg/kg + Midazolam load 0.2 mg/kg; Ketamine infusion 1-5 mg/kg/hr + Midazolam infusion 0.1-2 mg/kg/hr; titrate to burst suppression",
              "orderSentence": null
            },
            "contraindications": "Uncontrolled hypertension, elevated ICP (relative), hemodynamic instability (relative)",
            "monitoring": "2024 data: combination may reduce SE duration faster than midazolam alone",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Pentobarbital infusion",
            "dosing": {
              "instructions": "Load: 5-15 mg/kg IV at 50 mg/min; Infusion: start 0.5-1 mg/kg/hr, titrate to burst suppression; max 5 mg/kg/hr",
              "orderSentence": null
            },
            "contraindications": "Severe cardiac dysfunction",
            "monitoring": "cEEG, BP (significant hypotension - need pressors), cardiac output; longest half-life",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Super-Refractory SE - Additional Agents": [
          {
            "item": "Add second anesthetic",
            "dosing": {
              "instructions": "Combine midazolam + propofol, or add ketamine to either",
              "orderSentence": null
            },
            "contraindications": "Per agent",
            "monitoring": "cEEG, hemodynamics",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Topiramate (enteral)",
            "dosing": {
              "instructions": "Load 300-400 mg via NGT; then 200-400 mg BID; max 1600 mg/day",
              "orderSentence": null
            },
            "contraindications": "Metabolic acidosis, kidney stones",
            "monitoring": "Bicarbonate, renal function",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Lacosamide (if not tried)",
            "dosing": {
              "instructions": "400 mg IV, then 200-400 mg BID",
              "orderSentence": null
            },
            "contraindications": "PR prolongation",
            "monitoring": "ECG",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Perampanel (enteral)",
            "dosing": {
              "instructions": "4-8 mg via NGT daily; titrate to 12 mg daily",
              "orderSentence": null
            },
            "contraindications": "None absolute",
            "monitoring": "Aggression, sedation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Magnesium sulfate infusion",
            "dosing": {
              "instructions": "4-6 g IV over 20 min, then 1-2 g/hr infusion; target Mg 3.5-4 mg/dL",
              "orderSentence": null
            },
            "contraindications": "Renal failure (relative), myasthenia",
            "monitoring": "Mg levels, reflexes, respiratory status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pyridoxine (empiric trial)",
            "dosing": {
              "instructions": "100-500 mg IV; may try single dose empirically",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Response to treatment",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Ketogenic diet",
            "dosing": {
              "instructions": "Initiate within 7 days per NORSE consensus; requires nutrition support",
              "orderSentence": null
            },
            "contraindications": "Pyruvate carboxylase deficiency, fatty acid oxidation disorders",
            "monitoring": "Ketones, glucose, lipids",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Hypothermia (32-35°C)",
            "dosing": {
              "instructions": "Targeted temperature management x 24-48h",
              "orderSentence": null
            },
            "contraindications": "Coagulopathy, severe infection",
            "monitoring": "Temperature, coagulation, infection",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Electroconvulsive therapy",
            "dosing": {
              "instructions": "If all else fails; requires anesthesia",
              "orderSentence": null
            },
            "contraindications": "Raised ICP, recent stroke",
            "monitoring": "Per ECT protocol",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          },
          {
            "item": "Epilepsy surgery (emergent)",
            "dosing": {
              "instructions": "Resection if focal lesion identified",
              "orderSentence": null
            },
            "contraindications": "Eloquent cortex, multifocal",
            "monitoring": "Per surgical team",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "EXT"
          }
        ],
        "NORSE/FIRES Immunotherapy Protocol": [
          {
            "timing": "**Day 0-3**",
            "dosing": "See below"
          },
          {
            "timing": "**Day 3-7**",
            "dosing": "Add remaining first-line agents"
          },
          {
            "timing": "**Day 7**",
            "dosing": "Initiate with nutrition support"
          },
          {
            "timing": "**Day 7+**",
            "dosing": "If first-line inadequate"
          }
        ],
        "Symptomatic/Supportive ICU Care": [
          {
            "item": "Norepinephrine",
            "indication": "Hypotension from anesthetics",
            "dosing": {
              "instructions": "Start 0.1 mcg/kg/min; titrate to MAP ≥65",
              "orderSentence": null
            },
            "contraindications": "Hypovolemia (correct first)",
            "monitoring": "Arterial line, MAP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Vasopressin",
            "indication": "Adjunct pressor",
            "dosing": {
              "instructions": "0.04 units/min fixed dose",
              "orderSentence": null
            },
            "contraindications": "Cardiac ischemia",
            "monitoring": "MAP, cardiac status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Fentanyl infusion",
            "indication": "Analgesia/sedation adjunct",
            "dosing": {
              "instructions": "25-100 mcg/hr; titrate to comfort",
              "orderSentence": null
            },
            "contraindications": "Hemodynamic instability",
            "monitoring": "Pain scale, respiratory status",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Propofol (sub-anesthetic)",
            "indication": "Sedation during cEEG",
            "dosing": {
              "instructions": "5-50 mcg/kg/min",
              "orderSentence": null
            },
            "contraindications": "Propofol infusion syndrome risk, egg/soy allergy, pregnancy",
            "monitoring": "Sedation scale",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Dexmedetomidine",
            "indication": "Sedation, possible antiseizure",
            "dosing": {
              "instructions": "0.2-1.5 mcg/kg/hr",
              "orderSentence": null
            },
            "contraindications": "Bradycardia, heart block",
            "monitoring": "HR, BP",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pantoprazole",
            "indication": "Stress ulcer prophylaxis",
            "dosing": {
              "instructions": "40 mg IV daily",
              "orderSentence": null
            },
            "contraindications": "None significant",
            "monitoring": "GI bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Enoxaparin",
            "indication": "DVT prophylaxis",
            "dosing": {
              "instructions": "40 mg SC daily (start when stable)",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, recent LP",
            "monitoring": "Platelets, bleeding",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Insulin infusion",
            "indication": "Stress hyperglycemia",
            "dosing": {
              "instructions": "Per ICU protocol; target glucose 140-180 mg/dL",
              "orderSentence": null
            },
            "contraindications": "Hypoglycemia",
            "monitoring": "Glucose q1-4h",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Bowel regimen",
            "indication": "Constipation prophylaxis",
            "dosing": {
              "instructions": "Docusate 100 mg BID + senna 8.6 mg daily; escalate to bisacodyl or lactulose PRN",
              "orderSentence": null
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Bowel movements",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Skin care protocol",
            "indication": "Pressure injury prevention",
            "dosing": {
              "instructions": "Turn q2h, specialty mattress, moisture barrier, Braden scale assessment",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Skin integrity daily",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Eye care",
            "indication": "Corneal protection",
            "dosing": {
              "instructions": "Lubricating drops q4h, eyelid taping if incomplete closure",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Corneal integrity",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "STAT"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology/Epilepsy STAT consult",
            "indication": "All cases of SE",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Neurocritical care consult",
            "indication": "RSE/SRSE, need for anesthetic infusions",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "ICU admission",
            "indication": "All SE requiring second-line agents or ongoing seizures",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "EEG technologist/cEEG initiation",
            "indication": "Mandatory for RSE/SRSE; strongly recommended for all SE",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "Suspected CNS infection",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Rheumatology/Neuroimmunology consult",
            "indication": "NORSE/FIRES, suspected autoimmune encephalitis",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pharmacy consult",
            "indication": "Complex ASM dosing, drug interactions",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Nutrition/Dietitian consult",
            "indication": "Enteral feeding, ketogenic diet initiation (by Day 7 in NORSE)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Palliative care consult",
            "indication": "SRSE with poor prognosis, goals of care discussion",
            "ED": "—",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "ROUTINE"
          },
          {
            "item": "Social work consult",
            "indication": "Family support, discharge planning",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation",
            "indication": "Focal lesion on imaging, refractory to medical therapy",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "EXT"
          },
          {
            "item": "PT/OT/Speech evaluation",
            "indication": "Once stabilized; assess for deficits",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy outpatient follow-up",
            "indication": "All SE survivors; ASM optimization, etiology workup",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Outpatient video-EEG monitoring",
            "indication": "Characterization of seizure type, presurgical evaluation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Neuropsychology testing",
            "indication": "Cognitive assessment post-SE; baseline before surgery",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Explain SE is a medical emergency requiring ICU care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—"
          },
          {
            "item": "Discuss prognosis based on etiology and duration of SE",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—"
          },
          {
            "item": "Educate on importance of ASM adherence (if applicable)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Seizure first aid education for family",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Rescue medication training (rectal diazepam, nasal midazolam)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Driving restrictions (minimum 3-6 months seizure-free, varies by state)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Medical alert bracelet recommendation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Seizure action plan development",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Discuss goals of care if SRSE with poor prognosis",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE (ICU)"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Medication adherence counseling",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Avoid abrupt ASM discontinuation (common SE precipitant)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Alcohol cessation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Sleep hygiene (sleep deprivation lowers threshold)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Avoid known seizure triggers",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Drug interaction review (OTC, supplements)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          },
          {
            "item": "Pregnancy planning counseling (women of childbearing potential)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Psychogenic non-epileptic status",
        "features": "Preserved awareness, asynchronous movements, eye closure, pelvic thrusting, prolonged duration with minimal post-ictal period",
        "tests": "Video EEG, normal cEEG during event"
      },
      {
        "diagnosis": "Convulsive syncope",
        "features": "Brief (< 30 sec), occurs with LOC, myoclonic jerks possible",
        "tests": "History of prodrome, rapid recovery, normal EEG"
      },
      {
        "diagnosis": "Movement disorders (dystonia, chorea)",
        "features": "Non-rhythmic, preserved awareness, stereotyped pattern",
        "tests": "EEG normal during movements"
      },
      {
        "diagnosis": "Rigors (sepsis, transfusion reaction)",
        "features": "Associated with fever/chills, rhythmic shaking, preserves awareness",
        "tests": "Infectious workup, temperature, EEG normal"
      },
      {
        "diagnosis": "Decerebrate/decorticate posturing",
        "features": "Associated with structural brain injury, sustained posturing",
        "tests": "Imaging, cEEG"
      },
      {
        "diagnosis": "Drug-induced dyskinesia",
        "features": "Medication history, stereotyped movements",
        "tests": "Drug levels, history, EEG normal"
      },
      {
        "diagnosis": "Neuroleptic malignant syndrome",
        "features": "Rigidity, hyperthermia, AMS, autonomic instability",
        "tests": "CPK, medication history"
      },
      {
        "diagnosis": "Serotonin syndrome",
        "features": "Hyperreflexia, clonus, agitation, fever",
        "tests": "Medication history, clinical features"
      },
      {
        "diagnosis": "Tetanus",
        "features": "Sustained muscle contraction, trismus, opisthotonos",
        "tests": "History of wound, vaccination status"
      },
      {
        "diagnosis": "Strychnine poisoning",
        "features": "Opisthotonus with preserved consciousness",
        "tests": "Toxicology"
      }
    ],
    "evidence": [
      {
        "recommendation": "Benzodiazepines first-line for SE",
        "evidenceLevel": "Class I, Level A",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/); [AES Guidelines 2016](https://pubmed.ncbi.nlm.nih.gov/26900382/)"
      },
      {
        "recommendation": "Lorazepam preferred IV benzodiazepine",
        "evidenceLevel": "Class I, Level A",
        "source": "[Alldredge et al. NEJM 2001](https://pubmed.ncbi.nlm.nih.gov/11547716/)"
      },
      {
        "recommendation": "IM midazolam non-inferior to IV lorazepam",
        "evidenceLevel": "Class I, Level A",
        "source": "[RAMPART Trial, Silbergleit et al. NEJM 2012](https://pubmed.ncbi.nlm.nih.gov/22335736/)"
      },
      {
        "recommendation": "Second-line agents (LEV, VPA, fPHT) equivalent efficacy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial, Kapur et al. NEJM 2019;381:2103-2113](https://pubmed.ncbi.nlm.nih.gov/31774955/)"
      },
      {
        "recommendation": "Levetiracetam 60 mg/kg dosing",
        "evidenceLevel": "Class I, Level A",
        "source": "[ESETT Trial](https://pubmed.ncbi.nlm.nih.gov/31774955/) - higher than traditional 20-40 mg/kg"
      },
      {
        "recommendation": "Levetiracetam 40 mg/kg may be adequate",
        "evidenceLevel": "Class II, Level B",
        "source": "Meta-analysis, pharmacokinetic modeling 2023-2024"
      },
      {
        "recommendation": "cEEG monitoring in RSE",
        "evidenceLevel": "Class I, Level B",
        "source": "[NCS Guidelines 2012](https://pubmed.ncbi.nlm.nih.gov/22528274/)"
      },
      {
        "recommendation": "Burst suppression target for RSE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Expert consensus"
      },
      {
        "recommendation": "Ketamine in RSE/SRSE",
        "evidenceLevel": "Class IIb, Level B",
        "source": "Multiple case series; 2024 systematic reviews"
      },
      {
        "recommendation": "Earlier ketamine = better outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "2024 two-center study; systematic reviews"
      },
      {
        "recommendation": "Ketamine efficacy in RSE/SRSE",
        "evidenceLevel": "Class IIa, Level B",
        "source": "[Rosati A et al., CNS Drugs 2018;32(11):997-1009](https://pubmed.ncbi.nlm.nih.gov/30232735/)"
      },
      {
        "recommendation": "Ketamine ± midazolam superiority over midazolam alone",
        "evidenceLevel": "Class II, Level B",
        "source": "[Fletman et al., Clin Neurol Neurosurg 2024](https://pubmed.ncbi.nlm.nih.gov/39418930/); [Yan et al., J Neurol 2024](https://pubmed.ncbi.nlm.nih.gov/38782798/)"
      },
      {
        "recommendation": "NORSE first-line immunotherapy within 72h",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[Wickström et al. Epilepsia 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Ketogenic diet by Day 7 in NORSE",
        "evidenceLevel": "Class IIa, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35951466/); FIRES case series"
      },
      {
        "recommendation": "Second-line immunotherapy by Day 7 if first-line fails",
        "evidenceLevel": "Class IIb, Level C",
        "source": "[International Consensus 2022](https://pubmed.ncbi.nlm.nih.gov/35997591/)"
      },
      {
        "recommendation": "Brivaracetam for SE",
        "evidenceLevel": "Class IIb, Level C",
        "source": "Emerging evidence; case series"
      }
    ],
    "monitoring": [
      {
        "item": "Continuous EEG",
        "frequency": "Continuous",
        "action": "Adjust ASMs/anesthetics",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Cardiac telemetry",
        "frequency": "Continuous",
        "action": "Treat arrhythmia; assess ASM effect",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Pulse oximetry",
        "frequency": "Continuous",
        "action": "Increase O2, assess airway",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "q5min during treatment, then q1h",
        "action": "Pressors or antihypertensives",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Neurologic exam",
        "frequency": "q1-2h when off sedation",
        "action": "Imaging, reassess etiology",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "q1-4h",
        "action": "Insulin or dextrose",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Electrolytes (Na, K, Mg, Ca, Phos)",
        "frequency": "q6-12h",
        "action": "Replete deficiencies",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ABG/VBG",
        "frequency": "q4-6h (RSE), PRN",
        "action": "Adjust ventilator, treat acidosis",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Lactate",
        "frequency": "q6-12h",
        "action": "Treat underlying cause",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ASM levels",
        "frequency": "24h after load, then PRN",
        "action": "Adjust dosing",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "URGENT"
      },
      {
        "item": "Ammonia",
        "frequency": "q24h if on valproate",
        "action": "Reduce/stop valproate",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "LFTs",
        "frequency": "q24-48h",
        "action": "Adjust hepatically-metabolized ASMs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Renal function",
        "frequency": "q24h",
        "action": "Adjust renally-cleared ASMs",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "CPK",
        "frequency": "q12-24h if prolonged convulsions",
        "action": "Aggressive hydration, monitor renal",
        "ED": "—",
        "HOSP": "ROUTINE",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "Triglycerides",
        "frequency": "q24-48h if on propofol",
        "action": "Reduce propofol dose",
        "ED": "—",
        "HOSP": "—",
        "OPD": "—",
        "ICU": "ROUTINE"
      },
      {
        "item": "Temperature",
        "frequency": "q4h",
        "action": "Infection workup; cooling if hyperthermic",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "—",
        "ICU": "STAT"
      },
      {
        "item": "ICP (if monitored)",
        "frequency": "Continuous",
        "action": "ICP management protocol",
        "ED": "—",
        "HOSP": "—",
        "OPD": "—",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "ICU admission (REQUIRED)",
        "criteria": "All SE requiring second-line ASMs; all RSE/SRSE; altered mental status; need for airway management; hemodynamic instability"
      },
      {
        "disposition": "Step-down/Telemetry",
        "criteria": "Seizures controlled x 24h, off anesthetics x 24h, stable neuro exam, no airway concerns"
      },
      {
        "disposition": "General floor",
        "criteria": "Seizures controlled, off continuous monitoring, stable on oral ASMs, resolved AMS"
      },
      {
        "disposition": "Discharge home",
        "criteria": "Seizures controlled, stable on oral ASM regimen, etiology identified and addressed, family educated, follow-up arranged"
      },
      {
        "disposition": "Transfer to higher level care",
        "criteria": "Need for services unavailable (cEEG, neurocritical care, epilepsy surgery evaluation)"
      },
      {
        "disposition": "Long-term care/Rehab",
        "criteria": "Persistent deficits after prolonged SE, need for ongoing rehabilitation"
      },
      {
        "disposition": "Palliative/Hospice",
        "criteria": "SRSE with irreversible brain injury, goals of care established"
      }
    ]
  },
  "New Onset Seizure": {
    "id": "new-onset-seizure",
    "title": "New Onset Seizure",
    "version": "1.2",
    "icd10": [
      "** R56.9 (Unspecified convulsions)",
      "G40.909 (Epilepsy",
      "unspecified",
      "not intractable",
      "without status epilepticus)"
    ],
    "scope": "** Initial evaluation and management of first-time unprovoked seizure or first presentation of seizure activity in adults. Covers immediate stabilization, diagnostic workup to identify etiology, acute treatment, and framework for anti-seizure medication (ASM) initiation. Excludes status epilepticus (see \"Status Epilepticus\" template), pediatric seizures, febrile seizures, and known epilepsy with breakthrough seizures.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia is immediately reversible cause",
            "target": ">70 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before ASMs",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Electrolyte abnormalities (Na, Ca, Mg, glucose), renal/hepatic function for ASM dosing",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Magnesium",
            "rationale": "Hypomagnesemia lowers seizure threshold",
            "target": ">1.8 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Calcium (ionized if available)",
            "rationale": "Hypocalcemia can cause seizures",
            "target": "Normal (ionized 4.5-5.3 mg/dL)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Illicit drugs (cocaine, amphetamines) and withdrawal states",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood alcohol level",
            "rationale": "Alcohol intoxication or withdrawal",
            "target": "Correlate with history",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI can provoke seizures (especially elderly)",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Prolactin level",
            "rationale": "Elevated if drawn within 10-20 min of event; helps distinguish seizure from non-epileptic event",
            "target": "Elevated 2-3× baseline (if drawn <20 min)",
            "ED": "STAT",
            "HOSP": "—",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phosphorus",
            "rationale": "Hypophosphatemia lowers seizure threshold (especially alcohol withdrawal)",
            "target": ">2.5 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Lactate",
            "rationale": "Elevated post-ictal confirms recent seizure; metabolic acidosis screen",
            "target": "Mild elevation acceptable post-ictal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid dysfunction can affect seizure threshold",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ammonia",
            "rationale": "Hepatic encephalopathy, urea cycle disorders",
            "target": "Normal (<35 μmol/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Troponin",
            "rationale": "Cardiac ischemia as cause or consequence",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "ECG",
            "rationale": "Arrhythmia, prolonged QTc (some ASMs), Brugada",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Blood gas (ABG or VBG)",
            "rationale": "Acidosis, hypoxia",
            "target": "Normal or mild post-ictal acidosis",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Serum osmolality",
            "rationale": "Hypo/hyperosmolar states",
            "target": "280-295 mOsm/kg",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (urine or serum β-hCG)",
            "rationale": "Eclampsia; affects imaging and ASM choice",
            "target": "Negative (or explains eclampsia if positive)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "B12 level",
            "rationale": "Deficiency associated with seizures",
            "target": "Normal (>300 pg/mL)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Folate level",
            "rationale": "Deficiency can lower threshold; important for women of childbearing potential",
            "target": "Normal",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Serum/urine toxicology (expanded panel)",
            "rationale": "Synthetic drugs, medications not on standard screen",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Heavy metals (lead, mercury)",
            "rationale": "Occupational exposure, pica",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Ceruloplasmin, serum copper",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated CNS disease",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Autoimmune encephalitis panel (serum)",
            "rationale": "Anti-NMDAR, LGI1, CASPR2, GABA-B if clinical suspicion",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Paraneoplastic panel (serum)",
            "rationale": "Subacute onset, smoking, weight loss",
            "target": "Negative",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Porphyrins (urine/serum)",
            "rationale": "Acute intermittent porphyria",
            "target": "Normal",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Genetic epilepsy panel",
            "rationale": "Young onset, family history, refractory",
            "target": "Variable",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Elevated ICP, mass effect",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Infection, inflammation",
            "target": "WBC <5; RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Protein",
            "rationale": "Elevated in infection, inflammation",
            "target": "15-45 mg/dL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Low in bacterial/fungal/TB meningitis",
            "target": ">60% serum",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Bacterial meningitis",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "BioFire FilmArray ME Panel",
            "rationale": "Rapid pathogen identification (14 pathogens)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "HSV-1/2 PCR",
            "rationale": "HSV encephalitis (most common treatable cause)",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Autoimmune encephalitis panel (CSF)",
            "rationale": "If clinical suspicion for autoimmune etiology",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cytology",
            "rationale": "Carcinomatous meningitis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Oligoclonal bands",
            "rationale": "If demyelinating disease suspected",
            "target": "Negative or matched with serum",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "CT head without contrast",
            "timing": "Immediate in ED",
            "target": "Mass, hemorrhage, stroke, calcification, hydrocephalus",
            "contraindications": "Pregnancy (relative - benefit usually outweighs risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "MRI brain with and without contrast (epilepsy protocol)*",
            "timing": "Within 24-48h if inpatient; within 2 weeks if outpatient",
            "target": "Tumor, mesial temporal sclerosis, cortical dysplasia, encephalitis, stroke, vascular malformation",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "EEG (routine)",
            "timing": "Within 24h if possible; ideally within 24-48h of seizure",
            "target": "Epileptiform discharges (spikes, sharp waves), focal slowing",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended": [
          {
            "item": "Continuous EEG (cEEG) monitoring",
            "timing": "If altered mental status persists, suspected non-convulsive status",
            "target": "Non-convulsive seizures, non-convulsive status epilepticus",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Prolonged ambulatory EEG (24-72h)",
            "timing": "Outpatient if routine EEG non-diagnostic",
            "target": "Capture interictal or ictal activity",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Video-EEG monitoring",
            "timing": "If diagnosis uncertain (vs. psychogenic)",
            "target": "Correlate clinical events with EEG",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "MRA/MRV brain",
            "timing": "If vascular etiology suspected",
            "target": "AVM, aneurysm, venous thrombosis",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "CT angiography head",
            "timing": "If MRA unavailable and vascular cause suspected",
            "target": "Vascular malformation, aneurysm",
            "contraindications": "Contrast allergy, renal insufficiency",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Echocardiogram",
            "timing": "If embolic stroke suspected as cause",
            "target": "Thrombus, PFO, vegetation",
            "contraindications": "None significant",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Chest X-ray",
            "timing": "Aspiration risk post-ictal, lung cancer screening if paraneoplastic suspected",
            "target": "Clear lungs or mass",
            "contraindications": "None significant",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT brain (interictal FDG)",
            "timing": "Epilepsy surgery workup",
            "target": "Focal hypometabolism",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "SPECT (ictal/interictal)",
            "timing": "Epilepsy surgery workup",
            "target": "Ictal hyperperfusion",
            "contraindications": "Requires seizure capture",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "MEG (magnetoencephalography)",
            "timing": "Epilepsy surgery workup",
            "target": "Localize epileptogenic focus",
            "contraindications": "Metallic implants",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Neuropsychological testing",
            "timing": "Pre-surgical evaluation, cognitive concerns",
            "target": "Lateralizing deficits",
            "contraindications": "Patient cooperation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Wada test (intracarotid amobarbital)",
            "timing": "Pre-surgical language/memory lateralization",
            "target": "Language and memory dominance",
            "contraindications": "Contrast allergy, vascular anomaly",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Lorazepam IV/IM (if actively seizing)",
            "dosing": {
              "instructions": "0.1 mg/kg IV (max 4 mg); may repeat once in 5 min",
              "orderSentence": null
            },
            "contraindications": "Respiratory depression, severe hypotension",
            "monitoring": "RR, O2 sat, BP; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam IM (if no IV access)",
            "dosing": {
              "instructions": "10 mg IM (if >40 kg) or 0.2 mg/kg IM",
              "orderSentence": null
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat; have airway equipment ready",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Midazolam intranasal (if no IV access)",
            "dosing": {
              "instructions": "5 mg per nostril (total 10 mg)",
              "orderSentence": null
            },
            "contraindications": "Respiratory depression",
            "monitoring": "RR, O2 sat",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Dextrose 50% IV",
            "dosing": {
              "instructions": "25-50 mL IV if hypoglycemia confirmed or suspected",
              "orderSentence": null
            },
            "contraindications": "Hyperglycemia",
            "monitoring": "Glucose",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Thiamine IV",
            "dosing": {
              "instructions": "100-500 mg IV BEFORE glucose if alcohol use suspected",
              "orderSentence": null
            },
            "contraindications": "None significant",
            "monitoring": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "dosing": {
              "instructions": "2-4 L NC or non-rebreather as needed",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "O2 sat >94%",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic)",
            "dosing": {
              "instructions": "NS or LR bolus if hypotensive; maintenance if euvolemic",
              "orderSentence": null
            },
            "contraindications": "Fluid overload, severe hyponatremia",
            "monitoring": "I/O, BP, Na",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Flumazenil (rescue only)",
            "dosing": {
              "instructions": "0.2 mg IV over 30 sec; may repeat 0.2 mg q1min to max 1 mg",
              "orderSentence": null
            },
            "contraindications": "Chronic benzodiazepine use; seizure history; tricyclic overdose",
            "monitoring": "**CAUTION:** May lower seizure threshold and precipitate seizures; use only if severe respiratory depression unresponsive to supportive care",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Acute Loading": [
          {
            "item": "Levetiracetam IV",
            "indication": "First-line acute loading",
            "dosing": {
              "instructions": "40-60 mg/kg IV (max 4500 mg) over 15 min; OR 1500-3000 mg IV",
              "orderSentence": null
            },
            "contraindications": "None significant; reduce dose if CrCl <50",
            "monitoring": "Somnolence, agitation (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Levetiracetam PO",
            "indication": "Acute loading if stable",
            "dosing": {
              "instructions": "1500-3000 mg PO × 1, then start maintenance",
              "orderSentence": null
            },
            "contraindications": "Same",
            "monitoring": "Same",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "URGENT",
            "ICU": "—"
          },
          {
            "item": "Fosphenytoin IV",
            "indication": "Alternative first-line",
            "dosing": {
              "instructions": "20 mg PE/kg IV at 150 mg PE/min (max rate)",
              "orderSentence": null
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy (relative)",
            "monitoring": "Continuous cardiac monitoring, BP; purple glove syndrome rare with fosphenytoin",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Phenytoin IV",
            "indication": "If fosphenytoin unavailable",
            "dosing": {
              "instructions": "20 mg/kg IV at max 50 mg/min",
              "orderSentence": null
            },
            "contraindications": "AV block, sinus bradycardia, pregnancy",
            "monitoring": "Cardiac monitor, BP; give via large vein (tissue necrosis risk)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Valproate IV",
            "indication": "Alternative (broad-spectrum)",
            "dosing": {
              "instructions": "40 mg/kg IV over 10 min (max 3000 mg)",
              "orderSentence": null
            },
            "contraindications": "Pregnancy (teratogenic - neural tube defects), hepatic disease, mitochondrial disease, urea cycle disorders",
            "monitoring": "LFTs, ammonia, platelets; pancreatitis risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "—",
            "ICU": "STAT"
          },
          {
            "item": "Lacosamide IV",
            "indication": "Alternative first-line",
            "dosing": {
              "instructions": "200-400 mg IV over 15-30 min",
              "orderSentence": null
            },
            "contraindications": "PR prolongation >200 ms, 2nd/3rd degree AV block",
            "monitoring": "ECG for PR interval; dizziness",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          }
        ],
        "Anti-Seizure Medications (ASMs) - Maintenance Therapy": [
          {
            "item": "Levetiracetam",
            "indication": "First-line maintenance",
            "dosing": {
              "instructions": "500-1500 mg PO/IV BID; start 500 mg BID, may increase by 500 mg/dose weekly; max 3000 mg/day",
              "orderSentence": null
            },
            "contraindications": "Renal impairment (adjust per CrCl)",
            "monitoring": "Behavioral changes (irritability, depression - \"Keppra rage\"); renal function",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Lamotrigine",
            "indication": "First-line (especially women of childbearing potential)",
            "dosing": {
              "instructions": "Start 25 mg daily × 2 weeks; then 50 mg daily × 2 weeks; then 100 mg daily; target 200-400 mg/day in divided doses",
              "orderSentence": null
            },
            "contraindications": "Slow titration required (SJS/TEN risk)",
            "monitoring": "Rash (stop if any rash; SJS/TEN risk higher with fast titration or valproate co-therapy)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Lacosamide",
            "indication": "First-line alternative",
            "dosing": {
              "instructions": "Start 100 mg PO BID; increase by 100 mg/day weekly; target 200-400 mg BID; max 400 mg BID",
              "orderSentence": null
            },
            "contraindications": "PR prolongation, 2nd/3rd degree AV block, severe hepatic impairment",
            "monitoring": "ECG at baseline and dose changes; dizziness, diplopia",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxcarbazepine",
            "indication": "Focal seizures",
            "dosing": {
              "instructions": "Start 300 mg PO BID; increase by 300-600 mg/day every week; target 1200-2400 mg/day in divided doses",
              "orderSentence": null
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia in 2-3%); HLA-B*1502 screening in at-risk populations",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Carbamazepine",
            "indication": "Focal seizures",
            "dosing": {
              "instructions": "Start 200 mg PO BID; increase by 200 mg/day weekly; target 800-1200 mg/day; max 1600 mg/day",
              "orderSentence": null
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Valproate/Divalproex",
            "indication": "Generalized seizures",
            "dosing": {
              "instructions": "Start 10-15 mg/kg/day in divided doses; increase by 5-10 mg/kg/week; target 1000-2000 mg/day; max 60 mg/kg/day",
              "orderSentence": null
            },
            "contraindications": "Pregnancy (teratogenic); hepatic disease; mitochondrial disease; pancreatitis history",
            "monitoring": "LFTs, ammonia, CBC, platelets at baseline, then q3-6mo; weight gain, hair loss, tremor",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Phenytoin",
            "indication": "Focal or generalized",
            "dosing": {
              "instructions": "300-400 mg daily (extended release) or divided TID (immediate release); adjust by level",
              "orderSentence": null
            },
            "contraindications": "Pregnancy (relative - fetal hydantoin syndrome); AV block",
            "monitoring": "Free phenytoin level (target 1-2 μg/mL); total level 10-20 μg/mL; CBC, LFTs; gingival hyperplasia, hirsutism",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Brivaracetam",
            "indication": "Alternative to levetiracetam",
            "dosing": {
              "instructions": "Start 50 mg PO BID; may increase to 100 mg BID; max 200 mg/day",
              "orderSentence": null
            },
            "contraindications": "Hepatic impairment (reduce dose)",
            "monitoring": "Less behavioral side effects than levetiracetam; somnolence; Schedule C-V",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Zonisamide",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "instructions": "Start 100 mg daily; increase by 100 mg every 2 weeks; target 300-400 mg daily; max 600 mg/day",
              "orderSentence": null
            },
            "contraindications": "Sulfonamide allergy; kidney stones",
            "monitoring": "Kidney stones (carbonic anhydrase inhibitor); oligohidrosis (pediatric); metabolic acidosis",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Topiramate",
            "indication": "Adjunctive or monotherapy",
            "dosing": {
              "instructions": "Start 25 mg BID; increase by 50 mg/day weekly; target 200-400 mg/day in divided doses; max 400 mg/day",
              "orderSentence": null
            },
            "contraindications": "Kidney stones; metabolic acidosis; glaucoma",
            "monitoring": "Cognitive impairment (\"dopamax\"); paresthesias; kidney stones; weight loss",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Clobazam",
            "indication": "Adjunctive therapy",
            "dosing": {
              "instructions": "Start 5-10 mg daily; increase by 5-10 mg weekly; max 40 mg/day in divided doses",
              "orderSentence": null
            },
            "contraindications": "Severe hepatic impairment; sleep apnea (untreated)",
            "monitoring": "Sedation; tolerance may develop; CYP2C19 poor metabolizers need lower dose",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Perampanel",
            "indication": "Adjunctive for focal or GTCS",
            "dosing": {
              "instructions": "Start 2 mg qHS; increase by 2 mg weekly; target 8-12 mg qHS; max 12 mg/day",
              "orderSentence": null
            },
            "contraindications": "None absolute",
            "monitoring": "Psychiatric effects (aggression, hostility); dizziness; take at bedtime; Schedule III",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Cenobamate",
            "indication": "Adjunctive for focal",
            "dosing": {
              "instructions": "Start 12.5 mg daily × 2 weeks; titrate slowly per package insert; target 200-400 mg daily",
              "orderSentence": null
            },
            "contraindications": "Familial short QT syndrome",
            "monitoring": "Very slow titration required (DRESS risk); QT shortening; titration pack available",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Phenobarbital",
            "indication": "Refractory or resource-limited",
            "dosing": {
              "instructions": "Load 15-20 mg/kg IV; maintenance 1-3 mg/kg/day (60-180 mg/day); target level 15-40 μg/mL",
              "orderSentence": null
            },
            "contraindications": "Porphyria; severe respiratory disease",
            "monitoring": "Sedation; cognitive effects; drug interactions (CYP inducer); level monitoring",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          }
        ],
        "Symptomatic Treatments": [
          {
            "item": "Acetaminophen",
            "indication": "Post-ictal headache",
            "dosing": {
              "instructions": "650-1000 mg PO/IV q6h PRN; max 3000 mg/day (2000 mg if liver disease)",
              "orderSentence": null
            },
            "contraindications": "Severe hepatic impairment",
            "monitoring": "LFTs if chronic use",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Ibuprofen",
            "indication": "Post-ictal headache",
            "dosing": {
              "instructions": "400-600 mg PO q6-8h PRN; max 2400 mg/day",
              "orderSentence": null
            },
            "contraindications": "Renal impairment; GI bleed; post-CABG",
            "monitoring": "Renal function if prolonged use",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Ondansetron",
            "indication": "Post-ictal nausea",
            "dosing": {
              "instructions": "4-8 mg IV/PO q8h PRN",
              "orderSentence": null
            },
            "contraindications": "QT prolongation; severe hepatic impairment",
            "monitoring": "QTc if multiple doses",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lorazepam",
            "indication": "Post-ictal agitation (if severe)",
            "dosing": {
              "instructions": "0.5-2 mg IV/PO PRN; use with caution",
              "orderSentence": null
            },
            "contraindications": "Respiratory depression; altered mental status",
            "monitoring": "RR, sedation level; avoid if post-ictal confusion resolving",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Sertraline",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "instructions": "Start 50 mg daily; increase by 25-50 mg q1-2 weeks; max 200 mg daily",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Suicidality monitoring weeks 1-4",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Escitalopram",
            "indication": "Depression/anxiety (chronic)",
            "dosing": {
              "instructions": "Start 10 mg daily; max 20 mg daily",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc if risk factors",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Melatonin",
            "indication": "Sleep disturbance",
            "dosing": {
              "instructions": "3-5 mg PO qHS",
              "orderSentence": null
            },
            "contraindications": "None significant",
            "monitoring": "Well tolerated; may help with ASM-related sleep disruption",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Trazodone",
            "indication": "Insomnia",
            "dosing": {
              "instructions": "25-100 mg PO qHS",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Orthostatic hypotension; priapism (rare)",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          }
        ],
        "Second-line/Refractory": [
          {
            "item": "Add second ASM",
            "dosing": {
              "instructions": "Choose complementary mechanism; see maintenance options",
              "orderSentence": null
            },
            "contraindications": "Per specific agent",
            "monitoring": "Per specific agent",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Epilepsy surgery evaluation referral",
            "dosing": {
              "instructions": "For drug-resistant epilepsy (failed 2+ appropriately chosen ASMs)",
              "orderSentence": null
            },
            "contraindications": "N/A",
            "monitoring": "N/A",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Vagus nerve stimulator (VNS)",
            "dosing": {
              "instructions": "For drug-resistant epilepsy not surgical candidates",
              "orderSentence": null
            },
            "contraindications": "N/A",
            "monitoring": "Device checks",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Dietary therapy (ketogenic diet, modified Atkins)",
            "dosing": {
              "instructions": "For drug-resistant epilepsy",
              "orderSentence": null
            },
            "contraindications": "Fatty acid oxidation disorders; pyruvate carboxylase deficiency",
            "monitoring": "Metabolic panels; lipids; kidney function",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neurology consult",
            "indication": "All new onset seizures for evaluation and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Epilepsy specialist referral",
            "indication": "Diagnostic uncertainty, refractory seizures, surgical candidacy",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "EEG technologist/neurodiagnostics",
            "indication": "EEG scheduling; continuous EEG if indicated",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Structural lesion requiring intervention (tumor, AVM, SDH)",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "EXT",
            "ICU": "URGENT"
          },
          {
            "item": "Medical toxicology consult",
            "indication": "Suspected drug/toxin-induced seizure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Infectious disease consult",
            "indication": "CNS infection confirmed or suspected",
            "ED": "—",
            "HOSP": "URGENT",
            "OPD": "—",
            "ICU": "URGENT"
          },
          {
            "item": "Oncology consult",
            "indication": "Brain tumor identified",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Psychiatry consult",
            "indication": "Depression, anxiety post-diagnosis; psychogenic non-epileptic spells suspected",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Social work consult",
            "indication": "Driving restrictions impact, employment concerns, insurance navigation",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Occupational therapy",
            "indication": "Work safety evaluation, activity modification",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Physical therapy",
            "indication": "If post-ictal weakness, falls, injury from seizure",
            "ED": "—",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Neuropsychology referral",
            "indication": "Cognitive complaints, pre-surgical evaluation",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Women's health/OB-GYN",
            "indication": "Contraception counseling (ASM interactions), pregnancy planning",
            "ED": "—",
            "HOSP": "—",
            "OPD": "ROUTINE",
            "ICU": "—"
          },
          {
            "item": "Epilepsy monitoring unit (EMU) admission",
            "indication": "Characterize seizure type, video-EEG monitoring, pre-surgical evaluation",
            "ED": "—",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "—"
          },
          {
            "item": "Driving evaluation/rehabilitation",
            "indication": "Return to driving assessment when eligible",
            "ED": "—",
            "HOSP": "—",
            "OPD": "EXT",
            "ICU": "—"
          }
        ],
        "Patient Instructions": [
          {
            "item": "**Return to ED immediately if:** recurrent seizure, prolonged seizure >5 minutes, head injury, persistent confusion, difficulty breathing, or status epilepticus",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Do NOT drive until cleared by neurology (driving restrictions per state guidelines; typically require seizure-free interval)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid operating heavy machinery, working at heights, or swimming alone",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Do not bathe alone; showers preferred over baths; keep bathroom door unlocked",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Inform employer if job involves safety-sensitive duties",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Take ASM exactly as prescribed; do NOT stop abruptly (risk of breakthrough seizures or status epilepticus)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid common seizure triggers: sleep deprivation, alcohol, illicit drugs, missed medications",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Keep a seizure diary: date, time, duration, description, triggers, post-ictal symptoms",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Wear medical identification (bracelet or necklace)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Educate family/coworkers on seizure first aid: stay with person, protect head, do NOT put anything in mouth, time the seizure, call 911 if >5 minutes",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Follow up with neurology within 1-2 weeks of discharge",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "—",
            "ICU": "—"
          },
          {
            "item": "Bring list of all medications (including OTC and supplements) to all appointments - many interact with ASMs",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Women: discuss contraception with provider; some ASMs reduce efficacy of hormonal contraception",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Report side effects (mood changes, rash, dizziness, cognitive issues) promptly; do NOT stop medication without calling",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid flashing/strobe lights if photosensitive seizures suspected",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Sleep hygiene: aim for 7-9 hours nightly; maintain regular sleep schedule",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid alcohol (lowers seizure threshold; interacts with ASMs)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid illicit drugs (especially stimulants: cocaine, amphetamines)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Stress management techniques",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Regular moderate exercise (not extreme sleep deprivation from overtraining)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Medication adherence: use pill organizers, phone alarms, refill reminders",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Folic acid supplementation 1-4 mg daily for women of childbearing potential (especially if on enzyme-inducing ASMs)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Bone health: vitamin D 1000-2000 IU daily; calcium as needed (enzyme-inducing ASMs affect bone density)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Avoid known personal triggers (flashing lights, certain foods, stress, if identified)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Home safety modifications: pad sharp furniture corners, avoid glass shower doors, use microwave instead of stovetop when alone",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Seizure alert devices or apps for those living alone (optional)",
            "ED": "—",
            "HOSP": "—",
            "OPD": "✓",
            "ICU": "—"
          },
          {
            "item": "Smoking cessation (increases ASM metabolism; general health)",
            "ED": "—",
            "HOSP": "✓",
            "OPD": "✓",
            "ICU": "—"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Syncope (convulsive syncope)",
        "features": "Brief (<15 sec), triggered by standing/Valsalva/micturition, rapid recovery, no post-ictal confusion, possible prodrome (lightheaded, tunnel vision)",
        "tests": "ECG, orthostatic vitals, tilt table test, echocardiogram"
      },
      {
        "diagnosis": "Psychogenic non-epileptic spells (PNES)",
        "features": "Variable/atypical semiology, prolonged duration, preserved awareness with bilateral movements, eye closure, pelvic thrusting, no post-ictal confusion, psychiatric comorbidity",
        "tests": "Video-EEG capturing event; normal prolactin"
      },
      {
        "diagnosis": "Transient ischemic attack (TIA)",
        "features": "Negative symptoms (weakness, numbness), no LOC, no convulsive activity",
        "tests": "MRI DWI, vascular imaging"
      },
      {
        "diagnosis": "Migraine with aura",
        "features": "Gradual onset, spreading symptoms, headache follows, stereotyped",
        "tests": "Clinical history, normal EEG"
      },
      {
        "diagnosis": "Hypoglycemia",
        "features": "Diaphoresis, tremor, confusion, rapid glucose corrects symptoms",
        "tests": "Fingerstick glucose"
      },
      {
        "diagnosis": "Cardiac arrhythmia",
        "features": "Palpitations, sudden LOC without warning, rapid recovery",
        "tests": "ECG, Holter monitor, event recorder, EP study"
      },
      {
        "diagnosis": "Transient global amnesia",
        "features": "Isolated anterograde amnesia, repetitive questioning, no convulsive activity",
        "tests": "Clinical presentation (self-limited), MRI DWI (hippocampal)"
      },
      {
        "diagnosis": "Sleep disorders (parasomnias, cataplexy)",
        "features": "Occur from sleep, specific features (cataplexy with emotion)",
        "tests": "Sleep study, clinical history"
      },
      {
        "diagnosis": "Movement disorders (dystonia, tics)",
        "features": "Stereotyped, no LOC, suppressible (tics), may have sensory urge",
        "tests": "Clinical history, video"
      },
      {
        "diagnosis": "Drug intoxication/withdrawal",
        "features": "History of substance use, known withdrawal timeline",
        "tests": "Toxicology screen, history"
      },
      {
        "diagnosis": "Metabolic encephalopathy",
        "features": "Gradual onset, diffuse abnormality, asterixis, no discrete seizures",
        "tests": "Labs (ammonia, glucose, Na), EEG (diffuse slowing)"
      }
    ],
    "evidence": [
      {
        "recommendation": "ILAE 2017 seizure classification",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2017"
      },
      {
        "recommendation": "ILAE 2014 practical definition of epilepsy",
        "evidenceLevel": "Class I",
        "source": "Fisher RS et al. Epilepsia 2014"
      },
      {
        "recommendation": "EEG within 24-48h increases yield",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter 2007"
      },
      {
        "recommendation": "MRI superior to CT for epilepsy evaluation",
        "evidenceLevel": "Class I, Level A",
        "source": "ILAE Commission Report 2019"
      },
      {
        "recommendation": "Levetiracetam non-inferior to phenytoin for acute seizure cessation",
        "evidenceLevel": "Class I, Level A",
        "source": "ESETT Trial, NEJM 2019"
      },
      {
        "recommendation": "Risk of recurrence after first unprovoked seizure ~40-50%",
        "evidenceLevel": "Class I",
        "source": "Hauser et al., NEJM 1998"
      },
      {
        "recommendation": "Starting ASM after first seizure reduces recurrence but not long-term remission",
        "evidenceLevel": "Class I, Level A",
        "source": "FIRST and MESS trials"
      },
      {
        "recommendation": "Lamotrigine and levetiracetam preferred in women of childbearing potential",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN/AES Guidelines 2009, MONEAD Study"
      },
      {
        "recommendation": "Driving restrictions reduce accident risk",
        "evidenceLevel": "Class II, Level B",
        "source": "Multiple observational studies"
      },
      {
        "recommendation": "Prolactin elevation supports diagnosis of epileptic seizure (if drawn <20 min)",
        "evidenceLevel": "Class II, Level B",
        "source": "Chen et al., Neurology 2005"
      },
      {
        "recommendation": "Continuous EEG detects non-convulsive status in altered patients",
        "evidenceLevel": "Class II, Level B",
        "source": "Claassen et al., Neurology 2004"
      },
      {
        "recommendation": "Folate supplementation reduces teratogenicity risk",
        "evidenceLevel": "Class II, Level B",
        "source": "AAN Practice Parameter"
      }
    ],
    "monitoring": [
      {
        "item": "Neurologic exam (level of consciousness, focal deficits)",
        "frequency": "Q1-2h in ED; Q4h inpatient; each visit OPD",
        "action": "If prolonged post-ictal state: continuous EEG to rule out non-convulsive status",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "Vital signs",
        "frequency": "Continuous in ED/ICU; Q4h floor",
        "action": "Treat hyperthermia, hypotension, hypoxia",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Respiratory monitoring (post-benzodiazepine)",
        "frequency": "RR q15min × 1h post-administration; SpO2 continuous",
        "action": "Supplemental O2; airway management; consider flumazenil only if severe",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Glucose",
        "frequency": "On arrival; repeat if altered",
        "action": "Dextrose if low",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "—",
        "ICU": "✓"
      },
      {
        "item": "Electrolytes (Na, Ca, Mg)",
        "frequency": "On arrival; daily if abnormal",
        "action": "Correct deficiencies; identify cause",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "ASM level (phenytoin, valproate, phenobarbital, carbamazepine)",
        "frequency": "Trough level 5-7 days after initiation or dose change; PRN",
        "action": "Adjust dose; check free level for phenytoin",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "LFTs",
        "frequency": "Baseline; q3-6 months on valproate, carbamazepine",
        "action": "Discontinue if hepatotoxicity; hold if transaminases >3× ULN",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "CBC",
        "frequency": "Baseline; q3-6 months on carbamazepine, valproate",
        "action": "Discontinue if significant bone marrow suppression",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "Sodium",
        "frequency": "Baseline; periodically on oxcarbazepine, carbamazepine",
        "action": "Reduce dose or switch if severe hyponatremia",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "EEG",
        "frequency": "Within 24-48h of first seizure; repeat if diagnosis unclear",
        "action": "Adjust treatment if epileptiform activity or non-convulsive seizures",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓"
      },
      {
        "item": "MRI brain",
        "frequency": "Within 2 weeks of first seizure; sooner if structural cause suspected",
        "action": "Address structural cause; refer to appropriate specialist",
        "ED": "—",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "—"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Single, self-limited seizure; returned to baseline; no dangerous etiology identified on initial workup; reliable adult supervision for 24h; ASM initiated or deferred with close follow-up; outpatient EEG and MRI arranged; understands return precautions and driving restriction"
      },
      {
        "disposition": "**Admit to floor (observation)**",
        "criteria": "Prolonged post-ictal period; multiple seizures; new structural lesion requiring monitoring; ASM loading requiring observation; social situation preventing safe discharge; need for inpatient EEG; new focal neurologic deficit"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Status epilepticus (current or recent); recurrent seizures despite treatment; need for continuous EEG monitoring; airway compromise; hemodynamic instability; significant aspiration; large structural lesion with mass effect; CNS infection"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "MRI unavailable; EEG unavailable; neurology not available for consultation; need for neurosurgical intervention unavailable at facility"
      }
    ]
  },
  "Multiple Sclerosis - New Diagnosis": {
    "id": "ms-new-diagnosis",
    "title": "Multiple Sclerosis - New Diagnosis",
    "version": "2.5",
    "icd10": [
      "** G35 (Multiple sclerosis)",
      "H46.9 (Optic neuritis",
      "if presenting symptom)",
      "G37.9 (Demyelinating disease of CNS",
      "unspecified)"
    ],
    "scope": "** Initial diagnostic workup and management of suspected or newly confirmed MS. Covers diagnostic criteria evaluation, mimics exclusion, acute symptom treatment, and DMT initiation framework. For established MS with acute relapse, use \"MS - Exacerbation\" template. For ongoing DMT management and monitoring, use \"MS - Maintenance\" template.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Infection screen, baseline before steroids",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP",
            "rationale": "Metabolic screen, renal function",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "TSH",
            "rationale": "Thyroid disease mimics MS",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency causes myelopathy",
            "target": "Normal (>300 pg/mL)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Folate",
            "rationale": "Folate deficiency causes myelopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitis screen",
            "target": "Normal (<20 mm/hr)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Urinalysis",
            "rationale": "UTI as symptom trigger",
            "target": "Negative",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Blood glucose",
            "rationale": "Pre-steroid baseline",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Glycemic status before steroids",
            "target": "<5.7%",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "Vitamin D (25-OH)",
            "rationale": "Low levels associated with MS risk/activity",
            "target": ">30 ng/mL",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Lupus/connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Anti-dsDNA",
            "rationale": "If ANA positive, lupus evaluation",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "**Mayo CDS1 Panel** (AQP4-IgG + MOG-IgG by FACS)",
            "rationale": "Combined NMO/MOGAD screen; cell-based assay is gold standard",
            "target": "Both negative",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "HIV",
            "rationale": "HIV-associated myelopathy/encephalopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Neurosyphilis mimics MS",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology",
            "rationale": "Endemic areas; neuroborreliosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Neurosarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "SjÃ¶gren syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "ANCA panel",
            "rationale": "CNS vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Copper, ceruloplasmin",
            "rationale": "Wilson disease (young patients)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Very long chain fatty acids",
            "rationale": "Adrenomyeloneuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Mitochondrial DNA studies",
            "rationale": "Leber hereditary optic neuropathy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (HLA-DRB1)",
            "rationale": "Research/prognostic, not diagnostic",
            "target": "Variable",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Inflammation, rule out infection",
            "target": "WBC <50 (mild pleocytosis acceptable); RBC 0"
          },
          {
            "item": "Protein",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Elevated in inflammation",
            "target": "Normal to mildly elevated (<100 mg/dL)"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Low in infection/carcinomatous",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out infection",
            "target": "No organisms"
          },
          {
            "item": "Oligoclonal bands (CSF AND serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal IgG synthesis",
            "target": "â‰¥2 CSF-specific bands (not in serum)"
          },
          {
            "item": "IgG index",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Intrathecal antibody synthesis",
            "target": ">0.7 = elevated"
          },
          {
            "item": "Myelin basic protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Active demyelination marker",
            "target": "May be elevated acutely"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Rule out malignancy",
            "target": "Negative"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "MRI brain with and without contrast (MS protocol)*",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "Within 24-48h if acute; within 2 weeks if stable",
            "target": "Periventricular, juxtacortical, infratentorial, or cord lesions; gadolinium enhancement = active",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI C-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain MRI",
            "target": "Cord lesions (short segment, peripheral, dorsal)",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          },
          {
            "item": "MRI T-spine with and without contrast",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "timing": "With brain/C-spine",
            "target": "Cord lesions",
            "contraindications": "GFR <30, gadolinium allergy, pacemaker"
          }
        ],
        "Extended": [
          {
            "item": "Visual evoked potentials (VEP)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "During workup",
            "target": "Prolonged P100 latency (subclinical optic nerve involvement)",
            "contraindications": "None significant"
          },
          {
            "item": "OCT (Optical coherence tomography)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "Baseline",
            "target": "RNFL thinning (prior optic neuritis)",
            "contraindications": "None significant"
          },
          {
            "item": "MRI orbits with contrast",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "timing": "If optic neuritis suspected",
            "target": "Optic nerve enhancement, swelling",
            "contraindications": "Gadolinium contraindications"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "CT chest",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If sarcoidosis suspected",
            "target": "Hilar lymphadenopathy",
            "contraindications": "Contrast allergy"
          },
          {
            "item": "PET-CT",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS lymphoma or paraneoplastic suspected",
            "target": "FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes"
          },
          {
            "item": "Conventional angiography",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "timing": "If CNS vasculitis suspected",
            "target": "Beading, stenosis",
            "contraindications": "Contrast allergy, renal failure"
          },
          {
            "item": "Brain biopsy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-",
            "timing": "Atypical cases, tumefactive lesions",
            "target": "Demyelination vs neoplasm vs other",
            "contraindications": "Coagulopathy, inaccessible location"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Methylprednisolone IV",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": {
              "instructions": "1000 mg IV daily Ã— 3-5 days",
              "orderSentence": null
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h (target <180), BP, mood, sleep, I/O"
          },
          {
            "item": "Omeprazole",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": {
              "instructions": "20-40 mg daily during steroids",
              "orderSentence": null
            },
            "contraindications": "PPI allergy",
            "monitoring": "None routine"
          },
          {
            "item": "Insulin sliding scale",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT",
            "dosing": {
              "instructions": "Per protocol if glucose >180 mg/dL",
              "orderSentence": null
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose q6h"
          },
          {
            "item": "Prednisone oral taper (optional)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "60 mg daily Ã— 7 days, then taper over 2 weeks",
              "orderSentence": null
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose, BP, mood"
          }
        ],
        "Symptomatic Treatments - First-line": [
          {
            "item": "Baclofen",
            "indication": "Spasticity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": {
              "instructions": "Start 5 mg TID; increase by 5 mg/dose every 3 days; max 80 mg/day in divided doses",
              "orderSentence": null
            },
            "contraindications": "Renal impairment (reduce dose)",
            "monitoring": "Sedation, weakness; do NOT stop abruptly (withdrawal risk)"
          },
          {
            "item": "Tizanidine",
            "indication": "Spasticity",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": {
              "instructions": "Start 2 mg qHS or TID; increase by 2-4 mg every 3-4 days; max 36 mg/day in 3 divided doses",
              "orderSentence": null
            },
            "contraindications": "Hepatic impairment; concurrent ciprofloxacin or fluvoxamine (CYP1A2 inhibitors)",
            "monitoring": "LFTs at baseline, 1, 3, 6 months; sedation; hypotension"
          },
          {
            "item": "Gabapentin",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": {
              "instructions": "Start 300 mg qHS; increase by 300 mg every 1-3 days; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": null
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, dizziness, peripheral edema"
          },
          {
            "item": "Pregabalin",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "dosing": {
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": null
            },
            "contraindications": "Renal impairment (adjust dose per CrCl)",
            "monitoring": "Sedation, weight gain, peripheral edema"
          },
          {
            "item": "Duloxetine",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 30 mg daily Ã— 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": null
            },
            "contraindications": "Hepatic impairment; concurrent MAOIs; uncontrolled narrow-angle glaucoma",
            "monitoring": "Nausea (usually transient), BP, discontinuation syndrome"
          },
          {
            "item": "Amitriptyline",
            "indication": "Neuropathic pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": null
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; narrow-angle glaucoma",
            "monitoring": "Anticholinergic effects; ECG if dose >100 mg/day"
          },
          {
            "item": "Carbamazepine",
            "indication": "Trigeminal neuralgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 100 mg BID; increase by 200 mg/day every 3-7 days; max 1200 mg/day",
              "orderSentence": null
            },
            "contraindications": "AV block; bone marrow suppression; concurrent MAOIs",
            "monitoring": "CBC, LFTs, sodium at baseline and periodically; HLA-B*1502 screening in at-risk populations"
          },
          {
            "item": "Oxcarbazepine",
            "indication": "Trigeminal neuralgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 300 mg BID; increase by 300 mg every 3 days; max 1200 mg BID",
              "orderSentence": null
            },
            "contraindications": "Hypersensitivity to carbamazepine",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening"
          },
          {
            "item": "Oxybutynin IR",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": null
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (especially elderly)"
          },
          {
            "item": "Oxybutynin ER",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 5-10 mg daily; max 30 mg daily",
              "orderSentence": null
            },
            "contraindications": "Urinary retention; uncontrolled narrow-angle glaucoma; GI obstruction",
            "monitoring": "Dry mouth, constipation, cognitive impairment (fewer than IR)"
          },
          {
            "item": "Solifenacin",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 5 mg daily; may increase to 10 mg daily",
              "orderSentence": null
            },
            "contraindications": "Urinary retention; gastric retention; uncontrolled narrow-angle glaucoma; severe hepatic impairment",
            "monitoring": "Dry mouth, constipation; preferred over oxybutynin if cognitive concerns"
          },
          {
            "item": "Mirabegron",
            "indication": "Bladder urgency",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": null
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects (beta-3 agonist)"
          },
          {
            "item": "Tamsulosin",
            "indication": "Urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.4 mg daily 30 minutes after same meal each day",
              "orderSentence": null
            },
            "contraindications": "Severe sulfonamide allergy (use caution)",
            "monitoring": "Orthostatic hypotension; retrograde ejaculation"
          },
          {
            "item": "Bethanechol",
            "indication": "Urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "10-50 mg TID-QID",
              "orderSentence": null
            },
            "contraindications": "Asthma; bradycardia; hypotension; GI/GU obstruction",
            "monitoring": "GI cramping, bronchospasm"
          },
          {
            "item": "Desmopressin",
            "indication": "Nocturia",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.1-0.4 mg qHS (oral) or 10-40 mcg intranasal",
              "orderSentence": null
            },
            "contraindications": "Hyponatremia risk; age >65 (relative); CHF; polydipsia",
            "monitoring": "Sodium at baseline, 1 week, 1 month, then periodically; fluid restrict evening"
          },
          {
            "item": "Amantadine",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "100 mg every morning; may add 100 mg early afternoon (before 2 PM); max 200 mg/day",
              "orderSentence": null
            },
            "contraindications": "Renal impairment (adjust dose); uncontrolled seizures",
            "monitoring": "Livedo reticularis; ankle edema; insomnia; hallucinations"
          },
          {
            "item": "Modafinil",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 100 mg every morning; may increase to 200 mg; max 400 mg/day",
              "orderSentence": null
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception; Schedule IV"
          },
          {
            "item": "Armodafinil",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 150 mg every morning; max 250 mg daily",
              "orderSentence": null
            },
            "contraindications": "Cardiac arrhythmia; LV hypertrophy; hepatic impairment",
            "monitoring": "BP, HR; may reduce efficacy of hormonal contraception; longer half-life; Schedule IV"
          },
          {
            "item": "Methylphenidate",
            "indication": "Fatigue",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 5 mg BID (morning and noon); max 60 mg/day",
              "orderSentence": null
            },
            "contraindications": "Marked anxiety; glaucoma; tics/Tourette; concurrent MAOIs",
            "monitoring": "BP, HR, mood; Schedule II"
          },
          {
            "item": "Dalfampridine",
            "indication": "Walking impairment",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "10 mg q12h (must be exactly 12 hours apart); do NOT exceed 20 mg/day",
              "orderSentence": null
            },
            "contraindications": "Seizure history; CrCl <50 mL/min",
            "monitoring": "Seizure risk (dose-dependent); UTI; insomnia"
          },
          {
            "item": "Sertraline",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 50 mg daily; increase by 25-50 mg every 1-2 weeks; max 200 mg daily",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs; pimozide",
            "monitoring": "Suicidality monitoring (especially weeks 1-4); serotonin syndrome; QTc at high doses"
          },
          {
            "item": "Escitalopram",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 10 mg daily; may increase to 20 mg after 1 week; max 20 mg daily",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs; pimozide; QT prolongation",
            "monitoring": "QTc if risk factors or dose >10 mg; suicidality monitoring"
          },
          {
            "item": "Fluoxetine",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 20 mg daily; may increase after several weeks; max 80 mg daily",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs; pimozide; thioridazine",
            "monitoring": "Long half-life (washout important); suicidality monitoring"
          },
          {
            "item": "Bupropion SR/XL",
            "indication": "Depression",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 150 mg SR daily; increase to 150 mg SR BID after 3 days (or 300 mg XL daily); max 400 mg/day",
              "orderSentence": null
            },
            "contraindications": "Seizure disorder; eating disorders; abrupt alcohol/benzo withdrawal",
            "monitoring": "Seizure risk; insomnia; no sexual side effects"
          },
          {
            "item": "Venlafaxine XR",
            "indication": "Depression/pain",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg every 4 days; max 225 mg daily",
              "orderSentence": null
            },
            "contraindications": "Uncontrolled hypertension; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome (taper slowly)"
          },
          {
            "item": "Mirtazapine",
            "indication": "Depression/insomnia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 15 mg qHS; may increase by 15 mg every 1-2 weeks; max 45 mg daily",
              "orderSentence": null
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Weight gain; sedation (lower at higher doses); agranulocytosis (rare)"
          },
          {
            "item": "Polyethylene glycol 3350",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "17 g (1 capful) in 8 oz liquid once daily; adjust to effect",
              "orderSentence": null
            },
            "contraindications": "Bowel obstruction; ileus",
            "monitoring": "Electrolytes if prolonged use; may take 1-3 days for effect"
          },
          {
            "item": "Docusate sodium",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": null
            },
            "contraindications": "Intestinal obstruction; concurrent mineral oil",
            "monitoring": "Minimal efficacy as monotherapy; best for stool softening"
          },
          {
            "item": "Senna",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": null
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; dependency with chronic daily use"
          },
          {
            "item": "Bisacodyl",
            "indication": "Constipation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "5-10 mg PO qHS or 10 mg PR PRN",
              "orderSentence": null
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping; electrolyte disturbance with overuse"
          },
          {
            "item": "Lubiprostone",
            "indication": "Constipation (refractory)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "24 mcg BID with food",
              "orderSentence": null
            },
            "contraindications": "Mechanical GI obstruction",
            "monitoring": "Nausea (common); dyspnea; diarrhea"
          },
          {
            "item": "Propranolol",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 20 mg BID; increase by 20-40 mg every 3-7 days; max 320 mg/day in divided doses",
              "orderSentence": null
            },
            "contraindications": "Asthma/COPD; bradycardia <50; heart block; decompensated CHF",
            "monitoring": "HR, BP; fatigue; depression; bronchospasm"
          },
          {
            "item": "Primidone",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 25 mg qHS; increase by 25 mg every week to 250 mg TID; usual dose 50-250 mg TID",
              "orderSentence": null
            },
            "contraindications": "Porphyria; hypersensitivity to phenobarbital",
            "monitoring": "Severe sedation initially (start very low); ataxia; nausea"
          },
          {
            "item": "Clonazepam",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 0.25-0.5 mg BID; increase by 0.5 mg every 3 days; max 6 mg/day",
              "orderSentence": null
            },
            "contraindications": "Severe hepatic impairment; myasthenia gravis; untreated narrow-angle glaucoma",
            "monitoring": "Sedation; dependence; falls risk; do NOT stop abruptly"
          },
          {
            "item": "Topiramate",
            "indication": "Tremor",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Start 25 mg daily; increase by 25 mg weekly; max 400 mg/day in divided doses",
              "orderSentence": null
            },
            "contraindications": "Metabolic acidosis; kidney stones",
            "monitoring": "Cognitive slowing (\"dopamax\"); paresthesias; kidney stones; weight loss"
          },
          {
            "item": "Dextromethorphan-quinidine",
            "indication": "Pseudobulbar affect",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20/10 mg daily Ã— 7 days, then 20/10 mg q12h",
              "orderSentence": null
            },
            "contraindications": "QT prolongation; concurrent MAOIs; concurrent quinidine/quinine; CYP2D6 substrate drugs",
            "monitoring": "ECG at baseline; QTc monitoring; multiple drug interactions"
          }
        ],
        "Second-line/Refractory (Acute Treatment)": [
          {
            "item": "Plasmapheresis (PLEX)",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": {
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": null
            },
            "contraindications": "Hemodynamic instability, sepsis, line contraindication",
            "monitoring": "BP, electrolytes, coags, fibrinogen, line infection"
          },
          {
            "item": "IVIG",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT",
            "dosing": {
              "instructions": "0.4 g/kg/day Ã— 5 days",
              "orderSentence": null
            },
            "contraindications": "IgA deficiency, renal failure, thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis"
          },
          {
            "item": "Extended IV steroids",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE",
            "dosing": {
              "instructions": "Additional 2-5 days methylprednisolone (total 5-10 days)",
              "orderSentence": null
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose q6h, BP, mood, sleep"
          },
          {
            "item": "ACTH gel (H.P. Acthar)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-",
            "dosing": {
              "instructions": "80 units IM/SC daily Ã— 2-3 weeks",
              "orderSentence": null
            },
            "contraindications": "Active untreated infection, uncontrolled diabetes, psychosis history",
            "monitoring": "Glucose, BP, electrolytes"
          }
        ],
        "Disease-Modifying Therapies (DMT) - OPD ONLY": [
          {
            "item": "**INJECTABLE - MODERATE EFFICACY**"
          },
          {
            "item": "Interferon beta-1a (Avonex)",
            "route": "IM",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "30 mcg IM once weekly",
              "orderSentence": "Interferon beta-1a (Avonex) - IM - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common (pretreat with NSAIDs/acetaminophen)"
          },
          {
            "item": "Interferon beta-1a (Rebif)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "22 or 44 mcg SC three times weekly (titrate over 4 weeks)",
              "orderSentence": "Interferon beta-1a (Rebif) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; injection site reactions"
          },
          {
            "item": "Interferon beta-1b (Betaseron/Extavia)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "250 mcg SC every other day (titrate over 6 weeks)",
              "orderSentence": "Interferon beta-1b (Betaseron/Extavia) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; flu-like symptoms common"
          },
          {
            "item": "Peginterferon beta-1a (Plegridy)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "125 mcg SC every 14 days (titrate over first 4 doses)",
              "orderSentence": "Peginterferon beta-1a (Plegridy) - SC - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH",
            "contraindications": "Depression (relative); decompensated liver disease",
            "monitoring": "CBC, LFTs q3-6mo; TSH annually; less frequent dosing"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 20mg",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg SC daily",
              "orderSentence": "Glatiramer acetate (Copaxone) 20mg - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Injection site reactions; post-injection systemic reaction (rare, self-limited)"
          },
          {
            "item": "Glatiramer acetate (Copaxone) 40mg",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "40 mg SC three times weekly (â‰¥48 hours apart)",
              "orderSentence": "Glatiramer acetate (Copaxone) 40mg - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same"
          },
          {
            "item": "Glatiramer acetate (Glatopa)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg SC daily or 40 mg SC three times weekly",
              "orderSentence": "Glatiramer acetate (Glatopa) - SC - see dosing"
            },
            "pretreatment": "None required",
            "contraindications": "Hypersensitivity",
            "monitoring": "Same (generic)"
          },
          {
            "item": "**ORAL - MODERATE EFFICACY**"
          },
          {
            "item": "Dimethyl fumarate (Tecfidera)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "120 mg BID Ã— 7 days, then 240 mg BID",
              "orderSentence": "Dimethyl fumarate (Tecfidera) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects (take with food); flushing (aspirin 30 min prior)"
          },
          {
            "item": "Diroximel fumarate (Vumerity)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "231 mg BID Ã— 7 days, then 462 mg BID",
              "orderSentence": "Diroximel fumarate (Vumerity) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; less GI side effects than Tecfidera; flushing"
          },
          {
            "item": "Monomethyl fumarate (Bafiertam)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "95 mg BID Ã— 7 days, then 190 mg BID",
              "orderSentence": "Monomethyl fumarate (Bafiertam) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs",
            "contraindications": "Lymphopenia <500 (discontinue)",
            "monitoring": "CBC q6mo (lymphocytes); LFTs; GI side effects; flushing"
          },
          {
            "item": "Teriflunomide (Aubagio)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "7 or 14 mg once daily",
              "orderSentence": "Teriflunomide (Aubagio) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, TB test, BP",
            "contraindications": "Pregnancy (Category X - teratogenic); severe hepatic impairment; concurrent leflunomide",
            "monitoring": "LFTs monthly Ã— 6 months, then periodically; BP; hair thinning; requires cholestyramine washout if pregnancy desired"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (S1P MODULATORS)**"
          },
          {
            "item": "Fingolimod (Gilenya)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.5 mg once daily",
              "orderSentence": "Fingolimod (Gilenya) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam (macular edema), VZV IgG (vaccinate if negative and wait 4 weeks)",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA (within 6 months)",
            "monitoring": "First-dose observation 6 hours (HR, BP q1h, ECG at 6h); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Siponimod (Mayzent)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Titration pack days 1-5, then 2 mg daily (1 mg if CYP2C9 *1/*3 or *2/*3)",
              "orderSentence": "Siponimod (Mayzent) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG, CYP2C9 genotype",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA; CYP2C9 *3/*3 genotype",
            "monitoring": "First-dose observation 6 hours; macular edema screen; lymphocytes; LFTs; genotype required"
          },
          {
            "item": "Ozanimod (Zeposia)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "0.23 mg daily Ã— 4 days, 0.46 mg daily Ã— 3 days, then 0.92 mg daily",
              "orderSentence": "Ozanimod (Zeposia) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA; concurrent MAOIs",
            "monitoring": "No first-dose observation required (slower titration); macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "Ponesimod (Ponvory)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "14-day titration pack, then 20 mg daily",
              "orderSentence": "Ponesimod (Ponvory) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, ECG, ophthalmology exam, VZV IgG",
            "contraindications": "Bradycardia <55; 2nd/3rd degree AV block; sick sinus syndrome; QTc >500 ms; recent MI/stroke/TIA",
            "monitoring": "No first-dose observation required; macular edema screen at 3-4 months; lymphocytes; LFTs"
          },
          {
            "item": "**ORAL - HIGH EFFICACY (OTHER)**"
          },
          {
            "item": "Cladribine (Mavenclad)",
            "route": "PO",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Year 1: 1.75 mg/kg divided into 2 treatment weeks (week 1 and week 5); Year 2: repeat same dosing; no treatment years 3-4",
              "orderSentence": "Cladribine (Mavenclad) - PO - see dosing"
            },
            "pretreatment": "CBC, LFTs, HIV, Hepatitis B/C, TB, VZV IgG",
            "contraindications": "Active infection; HIV; active malignancy; pregnancy/breastfeeding; CrCl <30",
            "monitoring": "CBC at months 2 and 6 of each treatment year; lymphopenia expected and desired; screen for malignancy"
          },
          {
            "item": "**INFUSION - HIGH EFFICACY**"
          },
          {
            "item": "Natalizumab (Tysabri)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "300 mg IV every 4 weeks (or extended interval q6 weeks if stable and JCV negative)",
              "orderSentence": "Natalizumab (Tysabri) - IV - see dosing"
            },
            "pretreatment": "JCV antibody, CBC, LFTs",
            "contraindications": "JCV antibody positive with index >1.5 and prior immunosuppression (high PML risk); active infection",
            "monitoring": "JCV antibody q6mo; MRI for PML surveillance q6-12mo; infusion reactions; REMS program required"
          },
          {
            "item": "Ocrelizumab (Ocrevus)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 300 mg IV Ã— 2 doses 14 days apart; Maintenance: 600 mg IV every 6 months",
              "orderSentence": "Ocrelizumab (Ocrevus) - IV - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate with methylprednisolone, antihistamine, acetaminophen)"
          },
          {
            "item": "Ofatumumab (Kesimpta)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 20 mg SC at weeks 0, 1, 2; Maintenance: 20 mg SC monthly starting week 4",
              "orderSentence": "Ofatumumab (Kesimpta) - SC - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; self-administered at home"
          },
          {
            "item": "Ublituximab (Briumvi)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Initial: 150 mg IV day 1, 450 mg IV day 15; Maintenance: 450 mg IV every 24 weeks",
              "orderSentence": "Ublituximab (Briumvi) - IV - see dosing"
            },
            "pretreatment": "Hepatitis B serology, TB test, immunoglobulins",
            "contraindications": "Active Hepatitis B; active infection",
            "monitoring": "Immunoglobulins annually; infection monitoring; infusion reactions (premedicate); 1-hour infusion"
          },
          {
            "item": "Alemtuzumab (Lemtrada)",
            "route": "IV",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "Year 1: 12 mg IV daily Ã— 5 consecutive days; Year 2: 12 mg IV daily Ã— 3 consecutive days (12 months after year 1)",
              "orderSentence": "Alemtuzumab (Lemtrada) - IV - see dosing"
            },
            "pretreatment": "CBC, LFTs, TSH, creatinine, urinalysis, Hepatitis B/C, VZV IgG, TB, HPV screening",
            "contraindications": "Active infection; HIV; ongoing autoimmune disease other than MS",
            "monitoring": "CBC monthly Ã— 48 months; TSH q3mo Ã— 48 months; creatinine/urinalysis monthly Ã— 48 months; REMS program; secondary autoimmunity risk (thyroid, ITP, nephropathy)"
          },
          {
            "item": "**MODERATE EFFICACY - SPECIAL POPULATIONS**"
          },
          {
            "item": "Glatiramer acetate (Copaxone)",
            "route": "SC",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "dosing": {
              "instructions": "20 mg daily or 40 mg TIW",
              "orderSentence": "Glatiramer acetate (Copaxone) - SC - see dosing"
            },
            "pretreatment": "None",
            "contraindications": "Hypersensitivity",
            "monitoring": "Preferred in pregnancy (no evidence of harm)"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "MS specialist/Neuroimmunology referral",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "All new MS diagnoses for DMT discussion"
          },
          {
            "item": "Neuro-ophthalmology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Optic neuritis, visual symptoms, OCT baseline"
          },
          {
            "item": "Physical therapy consult for gait and balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE",
            "indication": "Gait dysfunction, lower extremity weakness, falls"
          },
          {
            "item": "Occupational therapy consult for ADL assessment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Upper extremity dysfunction, ADL impairment, energy conservation"
          },
          {
            "item": "Speech therapy for swallow evaluation",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT",
            "indication": "Brainstem involvement, dysphagia, dysarthria"
          },
          {
            "item": "Speech therapy for cognitive rehabilitation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Cognitive complaints affecting function"
          },
          {
            "item": "Urology referral for bladder dysfunction",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Urgency, frequency, retention, recurrent UTI"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Depression, anxiety, adjustment to diagnosis"
          },
          {
            "item": "Social work consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Insurance navigation, disability questions, support resources"
          },
          {
            "item": "Rehabilitation medicine consult",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Significant functional impairment, comprehensive rehab needs"
          },
          {
            "item": "Infusion center coordination",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "PLEX scheduling; future DMT infusion planning"
          },
          {
            "item": "Ophthalmology referral (pre-DMT)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-",
            "indication": "Baseline macular exam before S1P modulator initiation"
          },
          {
            "item": "Genetic counseling",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-",
            "indication": "If atypical features, family history concerns"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if rapid vision loss, sudden weakness, difficulty breathing, or urinary retention",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid driving until cleared by neurology",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Heat may temporarily worsen symptoms (Uhthoff phenomenon) - this is not a new attack",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Expect temporary steroid side effects: insomnia, mood changes, increased appetite, metallic taste",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Keep symptom diary noting new or worsening symptoms",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop steroids abruptly if on oral taper",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Do not stop baclofen or tizanidine abruptly - risk of withdrawal/rebound spasticity",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Monitor blood sugars if diabetic - steroids elevate glucose",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid sick contacts while on high-dose steroids",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "-"
          },
          {
            "item": "Contact MS specialist before starting any new medications (drug interactions with DMTs)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Vaccinations should be completed before DMT initiation (especially live vaccines)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Pregnancy planning requires DMT discussion (some DMTs teratogenic, washout periods vary)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Report any signs of infection (fever, cough, dysuria) promptly",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Post-void residual check if difficulty emptying bladder or recurrent UTIs",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (smoking accelerates MS progression and disability)",
            "ED": "âœ“",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Vitamin D supplementation 2000-5000 IU daily (target serum 25-OH vitamin D >40 ng/mL)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Regular aerobic exercise 150 min/week as tolerated (improves fatigue, mood, function)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Resistance training 2-3Ã—/week",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Stress management and adequate sleep (7-8 hours nightly)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Avoid excessive heat exposure (hot tubs, saunas, prolonged direct sun, exercising in heat)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Cooling vest for outdoor activities in warm weather",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Maintain healthy weight (obesity associated with worse outcomes)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Limit alcohol intake (can worsen balance, cognition, bladder symptoms)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "âœ“"
          },
          {
            "item": "Ensure vaccinations up to date before DMT initiation (live vaccines contraindicated on many DMTs)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Fall prevention: remove loose rugs, ensure adequate lighting, use assistive devices if needed",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          },
          {
            "item": "Energy conservation techniques for fatigue management (pacing, prioritization, positioning)",
            "ED": "-",
            "HOSP": "âœ“",
            "OPD": "âœ“"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Neuromyelitis optica spectrum disorder (NMOSD)",
        "features": "Longitudinally extensive transverse myelitis (â‰¥3 segments), severe optic neuritis (often bilateral), area postrema syndrome (intractable nausea/vomiting), brain lesions in NMOSD-typical locations",
        "tests": "AQP4-IgG positive (Mayo CDS1 or NMOFS); MRI pattern different"
      },
      {
        "diagnosis": "MOG antibody disease (MOGAD)",
        "features": "Bilateral optic neuritis, ADEM-like presentation, longitudinally extensive myelitis, cortical encephalitis, better steroid response, more favorable prognosis",
        "tests": "MOG-IgG positive (Mayo CDS1 or MOGFS)"
      },
      {
        "diagnosis": "Acute disseminated encephalomyelitis (ADEM)",
        "features": "Monophasic (usually), encephalopathy, post-infectious, large poorly-defined lesions, pediatric predominance",
        "tests": "Clinical course, MRI pattern, MOG-IgG status"
      },
      {
        "diagnosis": "CNS vasculitis",
        "features": "Headache, encephalopathy, stroke-like episodes, multifocal infarcts",
        "tests": "Elevated ESR/CRP, angiography, brain/leptomeningeal biopsy"
      },
      {
        "diagnosis": "Neurosarcoidosis",
        "features": "Cranial neuropathies (especially VII), hypothalamic involvement, leptomeningeal enhancement, hilar adenopathy",
        "tests": "ACE level, chest CT, biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "CNS lymphoma",
        "features": "Progressive course, deep gray matter/periventricular involvement, homogeneous enhancement, older/immunocompromised",
        "tests": "CSF cytology/flow, FDG-PET, biopsy"
      },
      {
        "diagnosis": "Susac syndrome",
        "features": "Encephalopathy, hearing loss, branch retinal artery occlusions, corpus callosum \"snowball\" lesions",
        "tests": "Audiogram, fluorescein angiography, MRI pattern"
      },
      {
        "diagnosis": "Neurosyphilis",
        "features": "Progressive cognitive decline, tabes dorsalis, Argyll Robertson pupils, positive serology",
        "tests": "RPR/VDRL, CSF VDRL, FTA-ABS"
      },
      {
        "diagnosis": "HIV-associated myelopathy/encephalopathy",
        "features": "Risk factors, vacuolar myelopathy, cognitive impairment",
        "tests": "HIV testing, CD4 count"
      },
      {
        "diagnosis": "B12 deficiency myelopathy",
        "features": "Subacute combined degeneration, dorsal column signs, peripheral neuropathy, macrocytic anemia",
        "tests": "B12, MMA, homocysteine"
      },
      {
        "diagnosis": "Migraine with white matter lesions",
        "features": "Headache history, non-specific white matter changes, no enhancement, no cord lesions",
        "tests": "Clinical history, MRI pattern"
      },
      {
        "diagnosis": "Small vessel ischemic disease",
        "features": "Older age, vascular risk factors, periventricular caps/halos, no enhancement, no cord lesions",
        "tests": "Risk factor profile, MRI pattern"
      }
    ],
    "evidence": [
      {
        "recommendation": "2017 McDonald Criteria for MS diagnosis",
        "evidenceLevel": "Class I",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "MRI brain/spine with contrast for diagnosis",
        "evidenceLevel": "Class I, Level A",
        "source": "[Wattjes MP et al. Lancet Neurol 2021 (MAGNIMS)](https://pubmed.ncbi.nlm.nih.gov/34139157/)"
      },
      {
        "recommendation": "CSF OCBs can substitute for dissemination in time",
        "evidenceLevel": "Class II, Level B",
        "source": "[Thompson AJ et al. Lancet Neurol 2018](https://pubmed.ncbi.nlm.nih.gov/29275977/)"
      },
      {
        "recommendation": "IV methylprednisolone 1g Ã— 3-5 days for acute attacks",
        "evidenceLevel": "Class I, Level A",
        "source": "[Filippini et al. Cochrane 2000](https://pubmed.ncbi.nlm.nih.gov/11034713/); Expert consensus"
      },
      {
        "recommendation": "PLEX for steroid-refractory attacks",
        "evidenceLevel": "Class II, Level B",
        "source": "[Faissner et al. J Neurol 2016](https://pubmed.ncbi.nlm.nih.gov/27039388/)"
      },
      {
        "recommendation": "Cell-based assay (FACS) for NMO/MOG antibodies",
        "evidenceLevel": "Class I, Level B",
        "source": "[Waters et al. 2014](https://pubmed.ncbi.nlm.nih.gov/27840658/); [Pittock et al.](https://pmc.ncbi.nlm.nih.gov/articles/PMC3286228/)"
      },
      {
        "recommendation": "Vitamin D supplementation",
        "evidenceLevel": "Class II, Level B",
        "source": "[SOLAR trial](https://pubmed.ncbi.nlm.nih.gov/31594857/); [CHOLINE trial](https://pubmed.ncbi.nlm.nih.gov/31454777/)"
      },
      {
        "recommendation": "Smoking cessation reduces progression",
        "evidenceLevel": "Class II, Level B",
        "source": "[Hedström et al. Brain 2013](https://pubmed.ncbi.nlm.nih.gov/23365092/)"
      },
      {
        "recommendation": "Early DMT initiation improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[BENEFIT extension](https://pubmed.ncbi.nlm.nih.gov/26833940/); Multiple RCTs"
      },
      {
        "recommendation": "Dalfampridine for walking impairment",
        "evidenceLevel": "Class I, Level A",
        "source": "[Goodman et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19249634/)"
      },
      {
        "recommendation": "Exercise improves fatigue and function",
        "evidenceLevel": "Class I, Level B",
        "source": "[Heine et al. Cochrane 2015](https://pubmed.ncbi.nlm.nih.gov/26358158/)"
      }
    ],
    "monitoring": [
      {
        "item": "Blood glucose",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q6h during IV steroids",
        "action": "Insulin sliding scale; endocrine consult if persistent >250"
      },
      {
        "item": "Blood pressure",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift during steroids",
        "action": "Antihypertensives PRN"
      },
      {
        "item": "Mood and sleep",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Daily during steroids",
        "action": "Psychiatry consult; consider dose adjustment"
      },
      {
        "item": "Temperature",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift",
        "action": "Infection workup if febrile"
      },
      {
        "item": "Neurologic exam",
        "ED": "✓",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "✓",
        "frequency": "Daily (inpatient); each visit (OPD)",
        "action": "If worsening: re-image, consider PLEX"
      },
      {
        "item": "I/O and weight",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Daily (inpatient)",
        "action": "Diuretics if fluid overload"
      },
      {
        "item": "Respiratory status",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "-",
        "ICU": "✓",
        "frequency": "Q shift if cervical myelitis",
        "action": "ICU transfer if NIF >-20 (critical)"
      },
      {
        "item": "Post-void residual",
        "ED": "-",
        "HOSP": "✓",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "If retention suspected",
        "action": "Intermittent catheterization if >200 mL; urology referral"
      },
      {
        "item": "MRI (follow-up) - early",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "3 months after baseline",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "MRI (follow-up) - standard",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "6 months after baseline, then annually",
        "action": "DMT escalation discussion if new activity"
      },
      {
        "item": "Vitamin D level",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Annually",
        "action": "Increase supplementation if low"
      },
      {
        "item": "JCV antibody (if on natalizumab)",
        "ED": "-",
        "HOSP": "-",
        "OPD": "✓",
        "ICU": "-",
        "frequency": "Every 6 months",
        "action": "If positive/rising: PML risk stratification, consider DMT switch"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Mild symptoms; able to ambulate safely; reliable follow-up within 1-2 weeks; no IV steroids needed OR completing outpatient infusion; stable baseline function; understands return precautions"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Moderate-severe symptoms; needs IV steroids; functional decline requiring therapy; diagnostic uncertainty requiring expedited workup; unable to care for self at home"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Severe myelitis with respiratory compromise (NIF >-30 declining toward -20); brainstem involvement with airway risk or autonomic instability; severe encephalopathy"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "PLEX needed but unavailable; MS specialist not available for complex decision-making; MRI unavailable for urgent imaging"
      }
    ]
  },
  "Peripheral Neuropathy - New Diagnosis/Evaluation": {
    "id": "peripheral-neuropathy",
    "title": "Peripheral Neuropathy - New Diagnosis/Evaluation",
    "version": "2.2",
    "icd10": [
      "** G62.9 (Polyneuropathy",
      "unspecified)",
      "G60.9 (Hereditary and idiopathic neuropathy",
      "unspecified)",
      "G62.0 (Drug-induced polyneuropathy)",
      "G62.1 (Alcoholic polyneuropathy)",
      "G63 (Polyneuropathy in diseases classified elsewhere)",
      "E11.42 (Type 2 diabetes with diabetic polyneuropathy)",
      "E10.42 (Type 1 diabetes with diabetic polyneuropathy)",
      "G60.0 (Hereditary motor and sensory neuropathy - CMT)",
      "E85.1 (Neuropathic heredofamilial amyloidosis - hATTR)"
    ],
    "scope": "** Initial diagnostic workup and symptomatic management of suspected or newly diagnosed peripheral neuropathy. Covers etiologic evaluation, electrodiagnostic testing, pain management, and lifestyle modifications. For acute inflammatory neuropathies (GBS, CIDP), use dedicated templates. For diabetic neuropathy-specific management, this template applies but see also diabetes care protocols for glycemic optimization.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "CBC with differential",
            "rationale": "Anemia (B12), infection, malignancy screen",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CMP (BMP + LFTs)",
            "rationale": "Renal dysfunction (uremic neuropathy), hepatic disease, electrolytes",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Fasting glucose",
            "rationale": "Diabetes screening",
            "target": "<100 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes/prediabetes (most common cause)",
            "target": "<5.7%",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Vitamin B12",
            "rationale": "B12 deficiency neuropathy",
            "target": ">300 pg/mL",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Methylmalonic acid (MMA)",
            "rationale": "If B12 borderline (200-400); more sensitive",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Folate deficiency",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "TSH",
            "rationale": "Hypothyroidism causes neuropathy",
            "target": "Normal (0.4-4.0 mIU/L)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "ESR",
            "rationale": "Inflammatory/vasculitic process",
            "target": "Normal (<20 mm/hr)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CRP",
            "rationale": "Inflammatory marker",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          }
        ],
        "Extended Workup": [
          {
            "item": "Oral glucose tolerance test (2-hour)",
            "rationale": "Detects IGT missed by FBG/HbA1c; high yield in idiopathic neuropathy (34-62% have abnormal OGTT)",
            "target": "<140 mg/dL at 2h",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Serum protein electrophoresis (SPEP) with immunofixation",
            "rationale": "Monoclonal gammopathy (MGUS, myeloma)",
            "target": "No M-spike",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "24-hour urine protein electrophoresis (UPEP)",
            "rationale": "Light chain disease",
            "target": "No monoclonal protein",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Free light chains (kappa/lambda)",
            "rationale": "AL amyloidosis, light chain deposition",
            "target": "Normal ratio (0.26-1.65)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B1 (thiamine)",
            "rationale": "Alcoholism, malnutrition, bariatric surgery",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B6 (pyridoxine)",
            "rationale": "Deficiency OR toxicity (>200 mg/day) causes neuropathy",
            "target": "Normal (5-50 ng/mL)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin E",
            "rationale": "Malabsorption, cholestasis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Copper",
            "rationale": "Copper deficiency (zinc excess, bariatric surgery)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Zinc",
            "rationale": "Zinc excess suppresses copper",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated distal sensory polyneuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B surface antigen/antibody",
            "rationale": "Hepatitis B-associated PAN, cryoglobulinemia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis C antibody",
            "rationale": "HCV-associated cryoglobulinemia, vasculitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme serology (endemic areas)",
            "rationale": "Lyme neuroborreliosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA",
            "rationale": "Connective tissue disease screen",
            "target": "Negative or low titer",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "RPR/VDRL",
            "rationale": "Syphilitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatoid factor",
            "rationale": "Rheumatoid vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Anti-SSA/SSB (Ro/La)",
            "rationale": "SjÃƒÂ¶gren syndrome (small fiber)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ACE level",
            "rationale": "Sarcoidosis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Anti-MAG antibody",
            "rationale": "IgM paraproteinemic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
            "rationale": "If motor-predominant or acute onset (GBS variants)",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Paraneoplastic panel",
            "rationale": "Subacute sensory neuronopathy, weight loss, smoking",
            "target": "Negative (Anti-Hu, CV2)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Cryoglobulins",
            "rationale": "Hepatitis C, autoimmune, vasculitic neuropathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Anti-CASPR2, Anti-LGI1",
            "rationale": "Neuromyotonia, Morvan syndrome",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Fat pad or sural nerve biopsy",
            "rationale": "Amyloidosis, vasculitis, CIDP variants",
            "target": "No amyloid or vasculitis",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Genetic testing (CMT panel, TTR gene)",
            "rationale": "Hereditary neuropathy, familial amyloidosis",
            "target": "No pathogenic variant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Skin punch biopsy for IENFD",
            "rationale": "Small fiber neuropathy confirmation",
            "target": ">8.8 fibers/mm (varies by site/age)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Heavy metal panel (lead, arsenic, thallium, mercury)",
            "rationale": "Occupational/environmental exposure",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "rationale": "Inflammation, infection",
            "target": "WBC <5, RBC 0",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein",
            "rationale": "Albuminocytologic dissociation in GBS/CIDP",
            "target": "Normal 15-45 mg/dL; elevated in GBS/CIDP",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Glucose with serum glucose",
            "rationale": "Infection, carcinomatous meningitis",
            "target": "Normal (>60% serum)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Gram stain and culture",
            "rationale": "Rule out infection",
            "target": "No organisms",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cytology",
            "rationale": "Leptomeningeal carcinomatosis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "VDRL (CSF)",
            "rationale": "Neurosyphilis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lyme PCR/antibody index",
            "rationale": "Endemic areas",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Nerve conduction studies (NCS) and EMG",
            "timing": "Optimal 3-4 weeks after symptom onset (allows Wallerian degeneration to manifest); can be done earlier if acute weakness suspected",
            "target": "Pattern determines axonal vs demyelinating, distribution, severity",
            "contraindications": "Pacemaker (relative); anticoagulation for needle EMG (relative)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended": [
          {
            "item": "MRI spine (cervical/lumbar) with and without contrast",
            "timing": "If radiculopathy, myelopathy, or polyradiculopathy suspected",
            "target": "Nerve root enhancement (radiculopathy), cord signal change",
            "contraindications": "GFR <30, pacemaker, gadolinium allergy",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRI lumbar plexus with contrast",
            "timing": "Lumbosacral plexopathy, asymmetric proximal weakness",
            "target": "Plexus enhancement, mass lesion",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MRI brachial plexus with contrast",
            "timing": "Brachial plexopathy, Parsonage-Turner syndrome",
            "target": "Plexus enhancement, denervation changes",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Autonomic function testing (QSART, tilt table, HRV)",
            "timing": "Autonomic symptoms (orthostasis, anhidrosis, GI dysmotility)",
            "target": "Abnormal sudomotor or cardiovagal function",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Quantitative sensory testing (QST)",
            "timing": "Small fiber neuropathy evaluation",
            "target": "Abnormal thermal thresholds",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Chest X-ray",
            "timing": "Lung cancer (paraneoplastic), sarcoidosis",
            "target": "Normal",
            "contraindications": "Pregnancy (relative)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "CT chest/abdomen/pelvis",
            "timing": "Occult malignancy if paraneoplastic suspected",
            "target": "No mass",
            "contraindications": "Contrast allergy, renal impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "PET-CT",
            "timing": "Occult malignancy, amyloidosis",
            "target": "No FDG-avid lesions",
            "contraindications": "Pregnancy, uncontrolled diabetes",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Nerve ultrasound",
            "timing": "CIDP (nerve enlargement), entrapment",
            "target": "Normal nerve caliber",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "MR neurography",
            "timing": "Focal nerve pathology, plexopathy",
            "target": "Normal nerve signal/caliber",
            "contraindications": "GFR <30; pacemaker; gadolinium allergy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Sural nerve biopsy",
            "timing": "Vasculitic neuropathy, amyloidosis, CIDP",
            "target": "No vasculitis or amyloid deposits",
            "contraindications": "Coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "-",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent": [
          {
            "item": "Thiamine (if alcoholic or malnourished)",
            "route": "IV",
            "indication": "Wernicke prevention, thiamine deficiency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Thiamine (if alcoholic or malnourished) 500 mg IV"
                }
              ],
              "route": "IV",
              "instructions": "500 mg IV TID x 3 days, then 250 mg IV daily x 3-5 days, then oral",
              "orderSentence": "Thiamine (if alcoholic or malnourished) 500 mg IV"
            },
            "contraindications": "None significant",
            "monitoring": "Anaphylaxis (rare)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Vitamin B12 (if deficient)",
            "route": "IM",
            "indication": "B12 deficiency neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1000 mcg",
                  "orderSentence": "Vitamin B12 (if deficient) 1000 mcg IM"
                }
              ],
              "route": "IM",
              "instructions": "1000 mcg IM daily x 7 days, then weekly x 4 weeks, then monthly",
              "orderSentence": "Vitamin B12 (if deficient) 1000 mcg IM"
            },
            "contraindications": "Cobalt allergy",
            "monitoring": "Reticulocyte count at 1 week; B12 level at 1-2 months",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Glucose control optimization",
            "route": "IV/PO",
            "indication": "Diabetic neuropathy stabilization",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Per protocol",
                  "orderSentence": "Glucose control optimization Per protocol IV/PO"
                }
              ],
              "route": "IV/PO",
              "instructions": "Per diabetes protocol; target HbA1c <7%",
              "orderSentence": "Glucose control optimization Per protocol IV/PO"
            },
            "contraindications": "Hypoglycemia risk",
            "monitoring": "Glucose monitoring",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Symptomatic Treatments - Neuropathic Pain": [
          {
            "item": "Gabapentin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg qHS",
                  "orderSentence": "Gabapentin 300 mg qHS PO"
                },
                {
                  "text": "300 mg TID",
                  "orderSentence": "Gabapentin 300 mg TID PO"
                },
                {
                  "text": "600 mg TID",
                  "orderSentence": "Gabapentin 600 mg TID PO"
                },
                {
                  "text": "900 mg TID",
                  "orderSentence": "Gabapentin 900 mg TID PO"
                },
                {
                  "text": "1200 mg TID",
                  "orderSentence": "Gabapentin 1200 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg qHS; increase by 300 mg q1-3d; target 900-1800 mg TID; max 3600 mg/day",
              "orderSentence": "Gabapentin 300 mg qHS PO"
            },
            "contraindications": "Renal impairment (CrCl 30-59: max 1400 mg/day; CrCl 15-29: max 600 mg/day; CrCl <15: max 300 mg/day)",
            "monitoring": "Sedation, dizziness, peripheral edema; taper to discontinue",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Pregabalin",
            "route": "PO",
            "indication": "Neuropathic pain (first-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg BID",
                  "orderSentence": "Pregabalin 75 mg BID PO"
                },
                {
                  "text": "150 mg BID",
                  "orderSentence": "Pregabalin 150 mg BID PO"
                },
                {
                  "text": "225 mg BID",
                  "orderSentence": "Pregabalin 225 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Pregabalin 300 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 75 mg BID; increase to 150 mg BID after 1 week; max 300 mg BID",
              "orderSentence": "Pregabalin 75 mg BID PO"
            },
            "contraindications": "Renal impairment (adjust per CrCl); Class V controlled",
            "monitoring": "Sedation, weight gain, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Duloxetine",
            "route": "PO",
            "indication": "Neuropathic pain (first-line, diabetic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg daily",
                  "orderSentence": "Duloxetine 30 mg daily PO"
                },
                {
                  "text": "60 mg daily",
                  "orderSentence": "Duloxetine 60 mg daily PO"
                },
                {
                  "text": "90 mg daily",
                  "orderSentence": "Duloxetine 90 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 30 mg daily x 1 week; increase to 60 mg daily; max 120 mg/day",
              "orderSentence": "Duloxetine 30 mg daily PO"
            },
            "contraindications": "Hepatic impairment; CrCl <30; MAOIs; narrow-angle glaucoma",
            "monitoring": "Nausea, BP; discontinuation syndrome (taper 2+ weeks)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Venlafaxine XR",
            "route": "PO",
            "indication": "Neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "75 mg daily",
                  "orderSentence": "Venlafaxine XR 75 mg daily PO"
                },
                {
                  "text": "150 mg daily",
                  "orderSentence": "Venlafaxine XR 150 mg daily PO"
                },
                {
                  "text": "225 mg daily",
                  "orderSentence": "Venlafaxine XR 225 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 37.5-75 mg daily; increase by 75 mg q4-7d; max 225 mg daily",
              "orderSentence": "Venlafaxine XR 75 mg daily PO"
            },
            "contraindications": "Uncontrolled HTN; concurrent MAOIs",
            "monitoring": "BP monitoring; discontinuation syndrome",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amitriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Amitriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Amitriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Amitriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Amitriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Amitriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nortriptyline",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg qHS",
                  "orderSentence": "Nortriptyline 10 mg qHS PO"
                },
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Nortriptyline 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Nortriptyline 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Nortriptyline 75 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10-25 mg qHS; increase by 10-25 mg weekly; max 150 mg qHS",
              "orderSentence": "Nortriptyline 10 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; fewer anticholinergic effects than amitriptyline",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Desipramine",
            "route": "PO",
            "indication": "Neuropathic pain (second-line)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg qHS",
                  "orderSentence": "Desipramine 25 mg qHS PO"
                },
                {
                  "text": "50 mg qHS",
                  "orderSentence": "Desipramine 50 mg qHS PO"
                },
                {
                  "text": "75 mg qHS",
                  "orderSentence": "Desipramine 75 mg qHS PO"
                },
                {
                  "text": "100 mg qHS",
                  "orderSentence": "Desipramine 100 mg qHS PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg qHS; increase by 25 mg weekly; max 150 mg daily",
              "orderSentence": "Desipramine 25 mg qHS PO"
            },
            "contraindications": "Cardiac conduction abnormality; recent MI; urinary retention; glaucoma; elderly",
            "monitoring": "ECG if dose >100 mg/day; least anticholinergic of TCAs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carbamazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg BID",
                  "orderSentence": "Carbamazepine 100 mg BID PO"
                },
                {
                  "text": "200 mg BID",
                  "orderSentence": "Carbamazepine 200 mg BID PO"
                },
                {
                  "text": "300 mg BID",
                  "orderSentence": "Carbamazepine 300 mg BID PO"
                },
                {
                  "text": "400 mg BID",
                  "orderSentence": "Carbamazepine 400 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg BID; increase by 200 mg/day q3-7d; max 1200 mg/day",
              "orderSentence": "Carbamazepine 100 mg BID PO"
            },
            "contraindications": "AV block; bone marrow suppression; MAOIs",
            "monitoring": "CBC, LFTs, sodium; HLA-B*1502 screening in at-risk populations",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Oxcarbazepine",
            "route": "PO",
            "indication": "Trigeminal neuralgia, lancinating pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "300 mg BID",
                  "orderSentence": "Oxcarbazepine 300 mg BID PO"
                },
                {
                  "text": "600 mg BID",
                  "orderSentence": "Oxcarbazepine 600 mg BID PO"
                },
                {
                  "text": "900 mg BID",
                  "orderSentence": "Oxcarbazepine 900 mg BID PO"
                },
                {
                  "text": "1200 mg BID",
                  "orderSentence": "Oxcarbazepine 1200 mg BID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 300 mg BID; increase by 300 mg q3d; max 1200 mg BID",
              "orderSentence": "Oxcarbazepine 300 mg BID PO"
            },
            "contraindications": "Carbamazepine hypersensitivity",
            "monitoring": "Sodium (hyponatremia risk); HLA-B*1502 screening",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin cream 0.075%",
            "route": "TOP",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "Apply thin layer",
                  "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply TID-QID to affected area; takes 2-4 weeks for effect",
              "orderSentence": "Capsaicin cream 0.075% Apply thin layer TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Initial burning (decreases with use); wash hands after",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Capsaicin 8% patch (Qutenza)",
            "route": "TOP",
            "indication": "Localized neuropathic pain (refractory)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 patch",
                  "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply by healthcare provider for 30-60 min; may repeat q3 months",
              "orderSentence": "Capsaicin 8% patch (Qutenza) 1 patch TOP"
            },
            "contraindications": "Open wounds; avoid eyes/mucous membranes",
            "monitoring": "Must be applied in clinic; pretreat with topical lidocaine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lidocaine 5% patch",
            "route": "TOP",
            "indication": "Localized neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1-3 patches",
                  "orderSentence": "Lidocaine 5% patch 1-3 patches TOP"
                }
              ],
              "route": "TOP",
              "instructions": "Apply 1-3 patches to painful area for 12h on, 12h off",
              "orderSentence": "Lidocaine 5% patch 1-3 patches TOP"
            },
            "contraindications": "Severe hepatic impairment; broken skin",
            "monitoring": "Minimal systemic absorption; local irritation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Tramadol",
            "route": "PO",
            "indication": "Moderate neuropathic pain (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tramadol 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg q6h PRN; may use ER 100 mg daily; max 400 mg/day",
              "orderSentence": "Tramadol 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule IV)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tapentadol ER",
            "route": "PO",
            "indication": "Moderate-severe neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Tapentadol ER 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg BID; increase by 50 mg BID q3d; max 250 mg BID",
              "orderSentence": "Tapentadol ER 50 mg PO"
            },
            "contraindications": "Seizure disorder; MAOIs; SSRIs (serotonin syndrome)",
            "monitoring": "Serotonin syndrome; seizures; dependence (Schedule II)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Morphine ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "15 mg",
                  "orderSentence": "Morphine ER 15 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 15 mg q12h; titrate q1-2d; no max (titrate to effect)",
              "orderSentence": "Morphine ER 15 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Oxycodone ER",
            "route": "PO",
            "indication": "Severe refractory pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Oxycodone ER 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 10 mg q12h; titrate q1-2d",
              "orderSentence": "Oxycodone ER 10 mg PO"
            },
            "contraindications": "Respiratory depression; paralytic ileus; MAOIs",
            "monitoring": "Sedation, constipation, respiratory status; naloxone available (Schedule II)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Methadone",
            "route": "PO",
            "indication": "Severe refractory neuropathic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg",
                  "orderSentence": "Methadone 2.5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5-5 mg TID; titrate slowly (long half-life); specialist management",
              "orderSentence": "Methadone 2.5 mg PO"
            },
            "contraindications": "QT prolongation; QT-prolonging drugs",
            "monitoring": "ECG at baseline and with dose changes; QTc monitoring",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Symptomatic Treatments - Other Symptoms": [
          {
            "item": "Midodrine",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2.5 mg TID",
                  "orderSentence": "Midodrine 2.5 mg TID PO"
                },
                {
                  "text": "5 mg TID",
                  "orderSentence": "Midodrine 5 mg TID PO"
                },
                {
                  "text": "7.5 mg TID",
                  "orderSentence": "Midodrine 7.5 mg TID PO"
                },
                {
                  "text": "10 mg TID",
                  "orderSentence": "Midodrine 10 mg TID PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 2.5 mg TID (awakening, midday, mid-afternoon); increase by 2.5 mg q1-2wk; max 10 mg TID; NOT within 4h of bedtime",
              "orderSentence": "Midodrine 2.5 mg TID PO"
            },
            "contraindications": "Severe heart disease; urinary retention; pheochromocytoma",
            "monitoring": "Supine HTN (avoid lying flat within 4h); urinary retention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Fludrocortisone",
            "route": "PO",
            "indication": "Orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.1 mg daily",
                  "orderSentence": "Fludrocortisone 0.1 mg daily PO"
                },
                {
                  "text": "0.2 mg daily",
                  "orderSentence": "Fludrocortisone 0.2 mg daily PO"
                },
                {
                  "text": "0.3 mg daily",
                  "orderSentence": "Fludrocortisone 0.3 mg daily PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 0.1 mg daily; increase by 0.1 mg q1-2wk; max 0.3 mg daily",
              "orderSentence": "Fludrocortisone 0.1 mg daily PO"
            },
            "contraindications": "CHF; hypertension",
            "monitoring": "Potassium, BP, edema; hypokalemia; supine HTN",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Droxidopa (Northera)",
            "route": "PO",
            "indication": "Neurogenic orthostatic hypotension",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Droxidopa (Northera) 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 100 mg TID; increase by 100 mg TID q24-48h; max 600 mg TID; NOT within 3h of bedtime",
              "orderSentence": "Droxidopa (Northera) 100 mg PO"
            },
            "contraindications": "Concurrent ergot alkaloids",
            "monitoring": "Supine HTN; caution with MAOIs/triptans",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pyridostigmine",
            "route": "PO",
            "indication": "Orthostatic hypotension (off-label)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "30 mg",
                  "orderSentence": "Pyridostigmine 30 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "30-60 mg TID",
              "orderSentence": "Pyridostigmine 30 mg PO"
            },
            "contraindications": "Mechanical GI/GU obstruction; asthma (relative)",
            "monitoring": "Cholinergic effects; less supine HTN than midodrine",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Polyethylene glycol 3350",
            "route": "PO",
            "indication": "Constipation (autonomic)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17 g",
                  "orderSentence": "Polyethylene glycol 3350 17 g PO"
                }
              ],
              "route": "PO",
              "instructions": "17 g daily; adjust to effect",
              "orderSentence": "Polyethylene glycol 3350 17 g PO"
            },
            "contraindications": "Bowel obstruction",
            "monitoring": "Electrolytes with prolonged use",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Docusate sodium",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "100 mg",
                  "orderSentence": "Docusate sodium 100 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "100 mg BID; max 500 mg/day",
              "orderSentence": "Docusate sodium 100 mg PO"
            },
            "contraindications": "Intestinal obstruction",
            "monitoring": "Minimal efficacy alone",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Senna",
            "route": "PO",
            "indication": "Constipation",
            "dosing": {
              "doseOptions": [
                {
                  "text": "17.2 mg",
                  "orderSentence": "Senna 17.2 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "8.6-17.2 mg qHS; max 34.4 mg/day",
              "orderSentence": "Senna 17.2 mg PO"
            },
            "contraindications": "Intestinal obstruction; acute abdominal pain",
            "monitoring": "Cramping",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Metoclopramide",
            "route": "PO",
            "indication": "Gastroparesis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Metoclopramide 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "5-10 mg 30 min before meals and qHS; max 40 mg/day; limit 12 weeks (black box: TD)",
              "orderSentence": "Metoclopramide 10 mg PO"
            },
            "contraindications": "Bowel obstruction; Parkinson; TD history",
            "monitoring": "Tardive dyskinesia; QT prolongation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Domperidone",
            "route": "PO",
            "indication": "Gastroparesis (if metoclopramide CI)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Domperidone 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg TID before meals; max 30 mg/day",
              "orderSentence": "Domperidone 10 mg PO"
            },
            "contraindications": "QT prolongation; QT-prolonging drugs",
            "monitoring": "ECG at baseline; not FDA-approved",
            "ED": "-",
            "HOSP": "-",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Oxybutynin IR",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Oxybutynin IR 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg BID-TID; max 5 mg QID",
              "orderSentence": "Oxybutynin IR 5 mg PO"
            },
            "contraindications": "Urinary retention; narrow-angle glaucoma",
            "monitoring": "Dry mouth, constipation, cognitive impairment",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mirabegron",
            "route": "PO",
            "indication": "Bladder urgency",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Mirabegron 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25 mg daily; may increase to 50 mg daily",
              "orderSentence": "Mirabegron 25 mg PO"
            },
            "contraindications": "Uncontrolled hypertension",
            "monitoring": "BP monitoring; fewer anticholinergic effects",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tamsulosin",
            "route": "PO",
            "indication": "Urinary retention",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.4 mg",
                  "orderSentence": "Tamsulosin 0.4 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "0.4 mg daily 30 min after same meal each day",
              "orderSentence": "Tamsulosin 0.4 mg PO"
            },
            "contraindications": "Severe sulfonamide allergy",
            "monitoring": "Orthostatic hypotension (caution if orthostatic)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sildenafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Sildenafil 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "50 mg 30-60 min before activity; may adjust 25-100 mg; max 100 mg/day",
              "orderSentence": "Sildenafil 50 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Tadalafil",
            "route": "PO",
            "indication": "Erectile dysfunction",
            "dosing": {
              "doseOptions": [
                {
                  "text": "10 mg",
                  "orderSentence": "Tadalafil 10 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "10 mg before activity (max once daily) OR 2.5-5 mg daily",
              "orderSentence": "Tadalafil 10 mg PO"
            },
            "contraindications": "Concurrent nitrates; recent MI/stroke",
            "monitoring": "Hypotension; priapism",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hydroxyzine",
            "route": "PO",
            "indication": "Anxiety, pruritus",
            "dosing": {
              "doseOptions": [
                {
                  "text": "25 mg",
                  "orderSentence": "Hydroxyzine 25 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "25-50 mg TID-QID PRN; max 400 mg/day",
              "orderSentence": "Hydroxyzine 25 mg PO"
            },
            "contraindications": "QT prolongation (high doses)",
            "monitoring": "Sedation; anticholinergic effects",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Buspirone",
            "route": "PO",
            "indication": "Generalized anxiety",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5 mg",
                  "orderSentence": "Buspirone 5 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 5 mg TID; increase by 5 mg q2-3d; max 60 mg/day",
              "orderSentence": "Buspirone 5 mg PO"
            },
            "contraindications": "Concurrent MAOIs",
            "monitoring": "Takes 2-4 weeks for effect; no dependence",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Trazodone",
            "route": "PO",
            "indication": "Insomnia with chronic pain",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Trazodone 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 25-50 mg qHS; increase to 100-150 mg; max 200 mg qHS",
              "orderSentence": "Trazodone 50 mg PO"
            },
            "contraindications": "Concurrent MAOIs; QT prolongation",
            "monitoring": "QTc; priapism (rare); sedation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Melatonin",
            "route": "PO",
            "indication": "Insomnia (adjunct)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "3 mg",
                  "orderSentence": "Melatonin 3 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "3-5 mg qHS 30 min before bed",
              "orderSentence": "Melatonin 3 mg PO"
            },
            "contraindications": "None significant",
            "monitoring": "Generally well-tolerated",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Disease-Specific Treatments": [
          {
            "item": "IVIG",
            "route": "IV",
            "indication": "CIDP, MMN, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "2 g/kg",
                  "orderSentence": "IVIG 2 g/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "2 g/kg divided over 2-5 days (induction); maintenance 0.4-1 g/kg q2-4wk",
              "orderSentence": "IVIG 2 g/kg IV"
            },
            "pretreatment": "IgA level; renal function; CBC",
            "contraindications": "IgA deficiency (use IgA-depleted); renal failure; thrombosis risk",
            "monitoring": "Renal function, headache, thrombosis, infusion reactions",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Plasma exchange (PLEX)",
            "route": "IV",
            "indication": "CIDP, GBS",
            "dosing": {
              "doseOptions": [
                {
                  "text": "5-7 exchanges",
                  "orderSentence": "Plasma exchange (PLEX) 5-7 exchanges IV"
                }
              ],
              "route": "IV",
              "instructions": "5-7 exchanges over 10-14 days",
              "orderSentence": "Plasma exchange (PLEX) 5-7 exchanges IV"
            },
            "pretreatment": "Coags; fibrinogen; line access",
            "contraindications": "Hemodynamic instability; sepsis",
            "monitoring": "BP, electrolytes, coags, fibrinogen",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Prednisone",
            "route": "PO",
            "indication": "CIDP, vasculitic neuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "60 mg",
                  "orderSentence": "Prednisone 60 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "1 mg/kg/day (max 80 mg) x 4-6 weeks; taper over 3-6 months",
              "orderSentence": "Prednisone 60 mg PO"
            },
            "pretreatment": "Glucose; BP; DEXA if prolonged",
            "contraindications": "Active infection; uncontrolled DM; psychosis",
            "monitoring": "Glucose, BP, mood, bone density",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rituximab",
            "route": "IV",
            "indication": "Anti-MAG neuropathy, vasculitic neuropathy, refractory CIDP",
            "dosing": {
              "doseOptions": [
                {
                  "text": "375 mg/m2",
                  "orderSentence": "Rituximab 375 mg/m2 IV"
                }
              ],
              "route": "IV",
              "instructions": "375 mg/m2 IV weekly x 4 weeks OR 1000 mg IV x 2 doses 14 days apart",
              "orderSentence": "Rituximab 375 mg/m2 IV"
            },
            "pretreatment": "HBV serology; CBC; immunoglobulins",
            "contraindications": "Active hepatitis B; active infection",
            "monitoring": "HBV serology, infusion reactions, infection monitoring",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Azathioprine",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "50 mg",
                  "orderSentence": "Azathioprine 50 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "Start 50 mg daily; increase to 2-3 mg/kg/day over weeks",
              "orderSentence": "Azathioprine 50 mg PO"
            },
            "pretreatment": "TPMT genotype; CBC; LFTs",
            "contraindications": "TPMT deficiency; pregnancy",
            "monitoring": "CBC weekly x 1 month, then q2-4wk; LFTs monthly",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Mycophenolate mofetil",
            "route": "PO",
            "indication": "Steroid-sparing for CIDP, vasculitis",
            "dosing": {
              "doseOptions": [
                {
                  "text": "500 mg",
                  "orderSentence": "Mycophenolate mofetil 500 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "500 mg BID x 2 weeks, then 1000 mg BID",
              "orderSentence": "Mycophenolate mofetil 500 mg PO"
            },
            "pretreatment": "CBC; pregnancy test",
            "contraindications": "Pregnancy (teratogenic); concurrent azathioprine",
            "monitoring": "CBC q2wk x 3 months, then monthly; GI upset",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Cyclophosphamide",
            "route": "IV/PO",
            "indication": "Vasculitic neuropathy (severe)",
            "dosing": {
              "doseOptions": [
                {
                  "text": "1 mg/kg",
                  "orderSentence": "Cyclophosphamide 1 mg/kg PO"
                }
              ],
              "route": "PO",
              "instructions": "1-2 mg/kg/day PO OR 500-1000 mg/m2 IV monthly x 6 months",
              "orderSentence": "Cyclophosphamide 1 mg/kg PO"
            },
            "pretreatment": "CBC; UA; pregnancy test",
            "contraindications": "Pregnancy; bone marrow suppression; active infection",
            "monitoring": "CBC weekly; UA (hemorrhagic cystitis); cumulative dose limit",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Tafamidis (Vyndamax)",
            "route": "PO",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "61 mg",
                  "orderSentence": "Tafamidis (Vyndamax) 61 mg PO"
                }
              ],
              "route": "PO",
              "instructions": "61 mg (Vyndamax) or 80 mg (Vyndaqel) daily",
              "orderSentence": "Tafamidis (Vyndamax) 61 mg PO"
            },
            "pretreatment": "LFTs; cardiac eval",
            "contraindications": "None absolute",
            "monitoring": "LFTs; clinical response",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Patisiran (Onpattro)",
            "route": "IV",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "0.3 mg/kg",
                  "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
                }
              ],
              "route": "IV",
              "instructions": "0.3 mg/kg IV every 3 weeks",
              "orderSentence": "Patisiran (Onpattro) 0.3 mg/kg IV"
            },
            "pretreatment": "LFTs; vitamin A level",
            "contraindications": "None absolute",
            "monitoring": "Vitamin A supplementation required (RDA); infusion reactions",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Inotersen (Tegsedi)",
            "route": "SC",
            "indication": "hATTR amyloidosis with polyneuropathy",
            "dosing": {
              "doseOptions": [
                {
                  "text": "284 mg",
                  "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
                }
              ],
              "route": "SC",
              "instructions": "284 mg SC once weekly",
              "orderSentence": "Inotersen (Tegsedi) 284 mg SC"
            },
            "pretreatment": "Platelets; renal function; REMS enrollment",
            "contraindications": "Platelet <100K; prior glomerulonephritis from inotersen",
            "monitoring": "Platelets weekly (more frequent if <75K); renal q2wk; continue 8wk post-discontinuation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Neuromuscular neurology referral",
            "indication": "All new neuropathy diagnoses for etiology workup and management",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Electrodiagnostic medicine/EMG referral",
            "indication": "NCS/EMG for characterization (axonal vs demyelinating, pattern)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Physical therapy consult for balance and gait",
            "indication": "Gait instability, weakness, falls prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy consult for hand function",
            "indication": "Fine motor impairment, ADL difficulty",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Podiatry referral",
            "indication": "Diabetic neuropathy, foot care education, orthotics, wound prevention",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Endocrinology referral",
            "indication": "Diabetes management optimization if HbA1c not at goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Pain management/Anesthesia referral",
            "indication": "Refractory neuropathic pain, spinal cord stimulator evaluation",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rheumatology referral",
            "indication": "Suspected vasculitic neuropathy, connective tissue disease",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hematology/Oncology referral",
            "indication": "Paraproteinemic neuropathy, suspected malignancy, amyloidosis",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Genetic counseling referral",
            "indication": "Suspected hereditary neuropathy (CMT, hATTR), family history",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Psychiatry/Psychology referral",
            "indication": "Chronic pain management, depression, anxiety",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work consult",
            "indication": "Disability resources, insurance navigation, DME assistance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Wound care referral",
            "indication": "Diabetic foot ulcers, non-healing wounds",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Orthotics/Prosthetics",
            "indication": "AFOs for foot drop, custom orthotics",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/Dietitian referral",
            "indication": "Alcoholic neuropathy, nutritional deficiencies, bariatric surgery patients",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Addiction medicine/Psychiatry",
            "indication": "Alcohol use disorder, opioid risk mitigation",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Return to ED if sudden severe weakness, difficulty breathing, or rapid symptom progression",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Inspect feet daily for cuts, blisters, or wounds (use mirror for soles)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear well-fitting, protective footwear at all times (never barefoot)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Test bath water temperature with elbow or thermometer before entering (avoid burns)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid prolonged hot or cold exposure to affected extremities (impaired sensation increases injury risk)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Use night lights and handrails to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Report new numbness, weakness, or autonomic symptoms (dizziness, bladder changes)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Keep pain medication diary to track effectiveness and side effects",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not stop gabapentin/pregabalin abruptly - taper under medical guidance",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Neuropathic pain medications take 2-4 weeks to reach full effect",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid alcohol (worsens neuropathy, interacts with pain medications)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Rise slowly from sitting/lying position if orthostatic hypotension present",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Increase salt and fluid intake if orthostatic (unless contraindicated by cardiac/renal disease)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Wear compression stockings for orthostatic hypotension",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Do not drive until cleared if significant sensory loss or weakness affects pedal control",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "B12 injections: if self-administering, use proper technique and rotate injection sites",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Strict glycemic control (HbA1c <7% or individualized target) - most important modifiable factor",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Complete alcohol cessation (alcoholic neuropathy is reversible if early)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Smoking cessation (microvascular disease worsens neuropathy)",
            "ED": "Ã¢Å“â€œ",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular exercise as tolerated (improves circulation, glycemic control, reduces pain)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Balance exercises and strength training (PT-guided) to prevent falls",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Pool therapy/aquatic exercise (reduces fall risk while exercising)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Vitamin B12 supplementation if vegan/vegetarian or on metformin",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Review medications for neurotoxic agents (metronidazole, nitrofurantoin, chemotherapy, amiodarone, statins)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Avoid excessive vitamin B6 supplementation (>100 mg/day can cause neuropathy)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Blood pressure control (target <130/80 for diabetic patients)",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Weight loss if obese (reduces pressure on nerves, improves metabolic syndrome)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Fall prevention: remove throw rugs, ensure adequate lighting, use assistive devices",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Annual foot exams by podiatry or primary care for diabetic patients",
            "ED": "-",
            "HOSP": "Ã¢Å“â€œ",
            "OPD": "Ã¢Å“â€œ"
          },
          {
            "item": "Regular ophthalmology exams if diabetic (concurrent retinopathy common)",
            "ED": "-",
            "HOSP": "-",
            "OPD": "Ã¢Å“â€œ"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Diabetic polyneuropathy",
        "features": "Symmetric, length-dependent, sensory-predominant, feet before hands, burning/tingling",
        "tests": "HbA1c >6.5% (or 2-hour OGTT >200); NCS shows axonal sensorimotor polyneuropathy"
      },
      {
        "diagnosis": "Alcoholic neuropathy",
        "features": "History of chronic alcohol use, nutritional deficiency, burning feet",
        "tests": "History, thiamine level, liver function tests"
      },
      {
        "diagnosis": "Vitamin B12 deficiency",
        "features": "Subacute combined degeneration, myelopathy features (ataxia, Romberg), macrocytic anemia",
        "tests": "B12 <200 pg/mL or MMA elevated; may have cord signal changes on MRI"
      },
      {
        "diagnosis": "Chronic inflammatory demyelinating polyneuropathy (CIDP)",
        "features": "Progressive or relapsing weakness >8 weeks, proximal and distal, areflexia",
        "tests": "NCS shows demyelination; CSF protein elevated; nerve enlargement on ultrasound"
      },
      {
        "diagnosis": "Guillain-BarrÃƒÂ© syndrome (GBS)",
        "features": "Acute ascending weakness <4 weeks, areflexia, post-infectious",
        "tests": "NCS early may be normal then demyelinating; CSF albuminocytologic dissociation"
      },
      {
        "diagnosis": "Hereditary neuropathy (CMT)",
        "features": "Family history, pes cavus, hammertoes, childhood onset, slowly progressive",
        "tests": "Genetic testing; NCS shows uniform slowing in CMT1"
      },
      {
        "diagnosis": "Hereditary transthyretin amyloidosis (hATTR)",
        "features": "Autonomic dysfunction, carpal tunnel, cardiac involvement, family history",
        "tests": "TTR gene mutation; tissue biopsy with amyloid"
      },
      {
        "diagnosis": "Monoclonal gammopathy-associated neuropathy",
        "features": "Distal sensory-predominant, ataxia (IgM anti-MAG), older patient",
        "tests": "SPEP/UPEP; anti-MAG antibody; may need bone marrow biopsy"
      },
      {
        "diagnosis": "Vasculitic neuropathy",
        "features": "Mononeuritis multiplex pattern (asymmetric, stepwise), pain, systemic symptoms",
        "tests": "Elevated ESR/CRP; ANCA; nerve/muscle biopsy shows necrotizing vasculitis"
      },
      {
        "diagnosis": "Paraneoplastic sensory neuronopathy",
        "features": "Subacute onset, asymmetric, dorsal root ganglia involvement, weight loss",
        "tests": "Anti-Hu antibody; CT chest for small cell lung cancer"
      },
      {
        "diagnosis": "Radiculopathy",
        "features": "Dermatomal distribution, unilateral, neck/back pain, preserved reflexes outside affected root",
        "tests": "MRI spine; NCS/EMG shows radicular pattern"
      },
      {
        "diagnosis": "Lumbosacral plexopathy (diabetic amyotrophy)",
        "features": "Acute/subacute proximal weakness, thigh pain, unilateral then contralateral",
        "tests": "NCS/EMG; MRI lumbosacral plexus; diagnosis of exclusion"
      },
      {
        "diagnosis": "Small fiber neuropathy",
        "features": "Pain/autonomic symptoms with normal NCS, preserved reflexes",
        "tests": "Skin biopsy for IENFD; autonomic testing"
      },
      {
        "diagnosis": "Charcot-Marie-Tooth disease",
        "features": "Childhood/adolescent onset, pes cavus, distal atrophy, family history",
        "tests": "Genetic testing (PMP22 duplication most common)"
      },
      {
        "diagnosis": "Chemotherapy-induced peripheral neuropathy (CIPN)",
        "features": "Temporal relationship to neurotoxic chemotherapy (platinum, taxanes, vincristine)",
        "tests": "History; dose-dependent; may improve after discontinuation"
      },
      {
        "diagnosis": "HIV-associated distal sensory polyneuropathy",
        "features": "HIV+ patient, distal symmetric painful neuropathy",
        "tests": "HIV testing; CD4 count"
      },
      {
        "diagnosis": "Lyme disease",
        "features": "Endemic area, prior tick bite, radiculopathy, cranial neuropathy, polyradiculopathy",
        "tests": "Lyme serology; may need CSF analysis"
      },
      {
        "diagnosis": "Sarcoidosis",
        "features": "Multifocal neuropathy, cranial neuropathy (especially VII), pulmonary symptoms",
        "tests": "ACE level; chest imaging; biopsy (non-caseating granulomas)"
      },
      {
        "diagnosis": "Leprosy",
        "features": "Endemic areas, skin lesions, enlarged palpable nerves, anesthetic patches",
        "tests": "Skin smear/biopsy for AFB; nerve biopsy"
      }
    ],
    "evidence": [
      {
        "recommendation": "Diabetes is most common cause of polyneuropathy in developed countries",
        "evidenceLevel": "Class I",
        "source": "[Dyck PJ et al. Neurology 1993](https://pubmed.ncbi.nlm.nih.gov/8469345/)"
      },
      {
        "recommendation": "HbA1c <7% reduces neuropathy incidence in Type 1 DM",
        "evidenceLevel": "Class I, Level A",
        "source": "[DCCT/EDIC, Martin et al. Diabetes Care 2014](https://pubmed.ncbi.nlm.nih.gov/24356595/)"
      },
      {
        "recommendation": "Gabapentin, pregabalin, duloxetine first-line for painful diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[AAN/AANEM Practice Guideline 2022](https://pubmed.ncbi.nlm.nih.gov/34965987/)"
      },
      {
        "recommendation": "Tricyclic antidepressants effective for neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Finnerup NB et al. Lancet Neurol 2015](https://pubmed.ncbi.nlm.nih.gov/25575710/)"
      },
      {
        "recommendation": "NCS/EMG for characterization of peripheral neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "SPEP indicated in idiopathic neuropathy workup",
        "evidenceLevel": "Class II, Level B",
        "source": "[England JD et al. Neurology 2009](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "OGTT detects IGT in 34-62% of idiopathic neuropathy patients",
        "evidenceLevel": "Class II, Level B",
        "source": "[Singleton et al. Diabetes Care 2001](https://pubmed.ncbi.nlm.nih.gov/11473085/); [Hoffman-Snyder et al. Arch Neurol 2006](https://pubmed.ncbi.nlm.nih.gov/16769858/)"
      },
      {
        "recommendation": "Skin biopsy (IENFD) for small fiber neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[Lauria G et al. Eur J Neurol 2010](https://pubmed.ncbi.nlm.nih.gov/20642627/)"
      },
      {
        "recommendation": "IVIG first-line for CIDP",
        "evidenceLevel": "Class I, Level A",
        "source": "[EAN/PNS Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/33506534/)"
      },
      {
        "recommendation": "Thiamine supplementation in alcoholic neuropathy",
        "evidenceLevel": "Class II, Level B",
        "source": "[AAN Practice Parameter](https://pubmed.ncbi.nlm.nih.gov/19056666/)"
      },
      {
        "recommendation": "Foot care reduces amputations in diabetic neuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[ADA Standards of Care 2023: Foot Care](https://pubmed.ncbi.nlm.nih.gov/36507636/)"
      },
      {
        "recommendation": "Capsaicin 8% patch effective for localized neuropathic pain",
        "evidenceLevel": "Class I, Level A",
        "source": "[Qutenza Prescribing Information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022395s012lbl.pdf)"
      },
      {
        "recommendation": "Tafamidis for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Coelho T et al. Neurology 2012](https://pubmed.ncbi.nlm.nih.gov/22843282/)"
      },
      {
        "recommendation": "Patisiran/inotersen for hATTR polyneuropathy",
        "evidenceLevel": "Class I, Level A",
        "source": "[Adams D et al. NEJM 2018 (APOLLO)](https://pubmed.ncbi.nlm.nih.gov/29972753/); [Benson MD et al. NEJM 2018 (NEURO-TTR)](https://pubmed.ncbi.nlm.nih.gov/29972757/)"
      },
      {
        "recommendation": "Combination therapy for neuropathic pain improves outcomes",
        "evidenceLevel": "Class II, Level B",
        "source": "[Gilron I et al. Lancet 2009](https://pubmed.ncbi.nlm.nih.gov/19796802/)"
      }
    ],
    "monitoring": [
      {
        "item": "HbA1c",
        "frequency": "Every 3 months until stable, then every 6 months",
        "action": "Intensify glycemic therapy; endocrinology referral",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Vitamin B12",
        "frequency": "1-2 months after starting supplementation, then annually",
        "action": "Continue supplementation; rule out malabsorption",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Pain scores (0-10 NRS)",
        "frequency": "Each visit",
        "action": "Titrate medications; consider adjuncts or referral",
        "ED": "ROUTINE",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Foot exam",
        "frequency": "Every visit; comprehensive annually",
        "action": "Podiatry referral; wound care",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Blood pressure (supine and standing)",
        "frequency": "Each visit if orthostatic symptoms",
        "action": "Adjust orthostatic hypotension medications; consider compression",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Gait and fall risk assessment",
        "frequency": "Each visit",
        "action": "PT referral; assistive devices; home safety evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Creatinine clearance",
        "frequency": "Baseline; with renal disease, elderly, or gabapentinoid use; with dose changes",
        "action": "Adjust gabapentin: CrCl 30-59 max 900-1400 mg/day; CrCl 15-29 max 600 mg/day; CrCl <15 max 300 mg/day",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "LFTs (if on high-dose gabapentinoid)",
        "frequency": "Baseline, then annually",
        "action": "Dose adjustment if hepatic impairment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Renal function",
        "frequency": "Every 6-12 months",
        "action": "Adjust renally cleared medications (gabapentin, pregabalin)",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "CBC (if on immunotherapy)",
        "frequency": "Per medication protocol",
        "action": "Adjust immunosuppression dose; infection evaluation",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "NCS/EMG follow-up",
        "frequency": "6-12 months if treatment initiated; PRN for symptom change",
        "action": "If progressive despite treatment, reconsider diagnosis or escalate therapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "ECG (if on TCAs)",
        "frequency": "Baseline; with dose increases >100 mg",
        "action": "Reduce dose or switch medication",
        "ED": "URGENT",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "URGENT"
      },
      {
        "item": "Weight (if on gabapentinoid)",
        "frequency": "Each visit",
        "action": "Diet/exercise counseling; consider switch",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Depression/anxiety screening (PHQ-9, GAD-7)",
        "frequency": "Annually or with symptom concern",
        "action": "Psychiatry referral; pharmacotherapy",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Respiratory function (if GBS/CIDP suspected)",
        "frequency": "Q4h if concern; FVC and NIF",
        "action": "ICU transfer if FVC <20 or NIF >-30; intubation if declining",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Stable symptoms; chronic/slowly progressive course; ambulatory; reliable follow-up with neurology within 2-4 weeks; pain controlled; able to perform ADLs; no fall risk requiring inpatient therapy"
      },
      {
        "disposition": "**Admit to floor**",
        "criteria": "Acute/subacute progression concerning for GBS or CIDP; significant functional decline; falls requiring therapy evaluation; severe uncontrolled pain; new autonomic instability; workup requiring inpatient procedures (nerve biopsy, LP)"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "GBS with respiratory compromise (FVC <20 mL/kg, NIF >-30, or declining trajectory); autonomic instability with cardiac arrhythmia or BP lability; aspiration risk"
      },
      {
        "disposition": "**Transfer to higher level**",
        "criteria": "EMG/NCS not available urgently; neuromuscular specialist not available; PLEX/IVIG needed but not available; rehabilitation services not available"
      }
    ]
  },
  "Acute Ischemic Stroke": {
    "id": "acute-ischemic-stroke",
    "title": "Acute Ischemic Stroke",
    "version": "1.2",
    "icd10": [
      "** I63.9 (Cerebral infarction",
      "unspecified)",
      "I63.50 (Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery)",
      "I63.30 (Cerebral infarction due to thrombosis of unspecified cerebral artery)",
      "I63.40 (Cerebral infarction due to embolism of unspecified cerebral artery)",
      "G45.9 (Transient cerebral ischemic attack",
      "unspecified)"
    ],
    "scope": "** Emergency evaluation and treatment of acute ischemic stroke, including thrombolysis decision-making, mechanical thrombectomy candidacy, acute stroke unit care, secondary prevention, and etiologic workup. For hemorrhagic stroke, TIA, or venous sinus thrombosis, use dedicated templates.",
    "notes": [],
    "sections": {
      "Laboratory Workup": {
        "Essential/Core Labs": [
          {
            "item": "Point-of-care glucose",
            "rationale": "Hypoglycemia can mimic stroke; required before tPA",
            "target": "60-180 mg/dL",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "CBC with differential",
            "rationale": "Baseline; thrombocytopenia contraindication to tPA",
            "target": "Platelets >100K",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "PT/INR",
            "rationale": "Anticoagulation status; INR >1.7 contraindication to tPA",
            "target": "INR <1.7",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "PTT",
            "rationale": "Baseline; heparin effect assessment",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Basic metabolic panel",
            "rationale": "Electrolytes, renal function",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Troponin",
            "rationale": "Concurrent MI; cardioembolic source",
            "target": "Normal",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "BNP or NT-proBNP",
            "rationale": "Heart failure; atrial cardiopathy",
            "target": "Normal",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Lipid panel (fasting preferred)",
            "rationale": "Cardiovascular risk; statin candidacy",
            "target": "LDL target <70",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HbA1c",
            "rationale": "Diabetes as risk factor",
            "target": "<7% goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Extended Workup": [
          {
            "item": "TSH",
            "rationale": "Thyroid disease and atrial fibrillation",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "LFTs",
            "rationale": "Baseline for statin therapy",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Urine drug screen",
            "rationale": "Cocaine, amphetamine-induced stroke",
            "target": "Negative",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Pregnancy test (females of childbearing age)",
            "rationale": "tPA risk assessment",
            "target": "Negative (or counsel risks)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Hemoglobin A1c",
            "rationale": "Glycemic control assessment",
            "target": "<7% goal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ESR",
            "rationale": "Vasculitis screen",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "CRP",
            "rationale": "Inflammation; vasculitis",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Homocysteine",
            "rationale": "Hypercoagulable workup in young stroke",
            "target": "Normal (<15 umol/L)",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Vitamin B12",
            "rationale": "Hyperhomocysteinemia cause",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Folate",
            "rationale": "Hyperhomocysteinemia cause",
            "target": "Normal",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-beta2 glycoprotein)",
            "rationale": "Hypercoagulable workup; repeat in 12 weeks if positive",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Protein C, Protein S, Antithrombin III",
            "rationale": "Inherited thrombophilia (defer acute phase; check 2-4 weeks post-stroke)",
            "target": "Normal",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Factor V Leiden, Prothrombin gene mutation",
            "rationale": "Inherited thrombophilia",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANA, anti-dsDNA",
            "rationale": "Vasculitis, SLE",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "ANCA (c-ANCA, p-ANCA)",
            "rationale": "Primary CNS vasculitis; systemic vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Syphilis serology (RPR)",
            "rationale": "Infectious vasculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "HIV antibody",
            "rationale": "HIV-associated vasculopathy",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Hepatitis B and C serology",
            "rationale": "Associated with vasculitis",
            "target": "Negative",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lipoprotein(a)",
            "rationale": "Elevated in cryptogenic stroke",
            "target": "Normal (<50 nmol/L or <30 mg/dL)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Sickle cell screen",
            "rationale": "If clinical suspicion",
            "target": "Negative",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Fabry disease testing (alpha-galactosidase A, GLA gene)",
            "rationale": "Young cryptogenic stroke, especially with other Fabry features",
            "target": "Normal enzyme activity",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          }
        ],
        "Lumbar Puncture": [
          {
            "item": "Opening pressure",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Rule out elevated ICP",
            "target": "10-20 cm H2O"
          },
          {
            "item": "Cell count (tubes 1 and 4)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Vasculitis, infection",
            "target": "WBC <5, RBC 0"
          },
          {
            "item": "Protein",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Inflammation",
            "target": "Normal 15-45 mg/dL"
          },
          {
            "item": "Glucose with serum glucose",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Infection",
            "target": "Normal (>60% serum)"
          },
          {
            "item": "Gram stain and culture",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Bacterial meningitis",
            "target": "No organisms"
          },
          {
            "item": "VDRL (CSF)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Neurosyphilis",
            "target": "Negative"
          },
          {
            "item": "Cytology",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "rationale": "Malignancy",
            "target": "Negative"
          }
        ]
      },
      "Imaging & Studies": {
        "Essential/First-line": [
          {
            "item": "Non-contrast CT head (NCCT)",
            "timing": "STAT - door to CT <25 min target",
            "target": "No hemorrhage; early ischemic changes (ASPECTS score)",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "CT angiography head and neck (CTA)",
            "timing": "STAT with NCCT",
            "target": "Large vessel occlusion (LVO); carotid/vertebral stenosis",
            "contraindications": "Contrast allergy (premedicate), CKD (benefit usually outweighs risk in acute stroke)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "CT perfusion (CTP)",
            "timing": "If within extended window (6-24 hours) or wake-up stroke",
            "target": "Mismatch (ischemic penumbra salvageable)",
            "contraindications": "Contrast allergy (premedicate), CKD (benefit usually outweighs risk in acute stroke)",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "ECG (12-lead)",
            "timing": "STAT",
            "target": "Atrial fibrillation, STEMI, LVH",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          }
        ],
        "Extended": [
          {
            "item": "MRI brain with DWI",
            "timing": "Within 24 hours; better for small/posterior strokes",
            "target": "Acute infarct confirmation; lesion pattern",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "URGENT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "MRA head and neck",
            "timing": "With MRI if CTA not done",
            "target": "Stenosis, dissection, aneurysm",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "URGENT",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "URGENT"
          },
          {
            "item": "Transthoracic echocardiogram (TTE) with bubble study",
            "timing": "Within 24-48 hours",
            "target": "LV thrombus, PFO, valvular disease, wall motion abnormalities",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transesophageal echocardiogram (TEE)",
            "timing": "If TTE non-diagnostic and high suspicion for cardiac source; or PFO evaluation",
            "target": "LAA thrombus, aortic atheroma, PFO with atrial septal aneurysm",
            "contraindications": "Esophageal pathology",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid duplex ultrasound",
            "timing": "If CTA/MRA not done or for follow-up",
            "target": "Stenosis >50%",
            "contraindications": "None",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Transcranial Doppler (TCD) with bubble study",
            "timing": "PFO evaluation; vasospasm monitoring",
            "target": "Right-to-left shunt; microembolic signals",
            "contraindications": "Inadequate acoustic windows",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Continuous cardiac telemetry (minimum 24-72 hours)",
            "timing": "Paroxysmal AF detection",
            "target": "Atrial fibrillation",
            "contraindications": "None",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Extended cardiac monitoring (Holter 7-30 days or implantable loop recorder)",
            "timing": "Cryptogenic stroke; AF not detected on telemetry",
            "target": "Paroxysmal AF",
            "contraindications": "None significant",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Rare/Specialized": [
          {
            "item": "Conventional cerebral angiography (DSA)",
            "timing": "If vasculitis suspected; CNS vasculitis workup",
            "target": "Beading, stenosis, aneurysm",
            "contraindications": "Contrast allergy, CKD, coagulopathy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "High-resolution vessel wall MRI",
            "timing": "Vasculitis, intracranial atherosclerosis characterization",
            "target": "Wall enhancement pattern",
            "contraindications": "Pacemaker, metallic implants (check compatibility)",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Lumbar puncture",
            "timing": "If vasculitis, infectious, or inflammatory etiology suspected",
            "target": "See LP section",
            "contraindications": "See LP section",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "PET-CT or PET-MRI",
            "timing": "Occult malignancy workup; giant cell arteritis",
            "target": "No malignancy/inflammation",
            "contraindications": "Pregnancy",
            "ED": "-",
            "HOSP": "EXT",
            "OPD": "EXT",
            "ICU": "-"
          },
          {
            "item": "Implantable loop recorder (ILR)",
            "timing": "Cryptogenic stroke after negative workup",
            "target": "Paroxysmal AF detection",
            "contraindications": "Active infection",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Treatment": {
        "Acute/Emergent (Hyperacute Phase)": [
          {
            "item": "Alteplase (tPA) IV",
            "dosing": {
              "instructions": "0.9 mg/kg IV (max 90 mg); 10% as bolus over 1 min, remainder over 60 min; within 4.5 hours of symptom onset",
              "orderSentence": null
            },
            "contraindications": "See Appendix A for complete exclusion criteria; major: ICH, recent surgery, BP >185/110 despite treatment, INR >1.7, platelets <100K",
            "monitoring": "Neuro checks q15min x 2h, then q30min x 6h, then q1h x 16h; BP q15min x 2h, then q30min x 6h; hold antiplatelets/anticoagulants 24h; CT head before anticoagulation",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Tenecteplase IV",
            "dosing": {
              "instructions": "0.25 mg/kg IV bolus (max 25 mg); single bolus (no infusion); within 4.5 hours of symptom onset",
              "orderSentence": null
            },
            "contraindications": "See Appendix A; major: ICH, recent surgery, BP >185/110, INR >1.7, platelets <100K",
            "monitoring": "Neuro checks q15min x 2h, then q30min x 6h, then q1h x 16h; BP q15min x 2h; hold anticoagulants 24h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management (pre-thrombolysis) - Labetalol",
            "dosing": {
              "instructions": "10-20 mg IV over 1-2 min; may repeat or double q10min; max 300 mg",
              "orderSentence": null
            },
            "contraindications": "Asthma, severe bradycardia, decompensated HF, 2nd/3rd degree heart block",
            "monitoring": "Continuous BP; target BP <185/110 for tPA eligibility",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management (pre-thrombolysis) - Nicardipine",
            "dosing": {
              "instructions": "Start 5 mg/hr IV; increase by 2.5 mg/hr q5-15min; max 15 mg/hr",
              "orderSentence": null
            },
            "contraindications": "None significant",
            "monitoring": "Continuous BP; target <185/110",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management (pre-thrombolysis) - Clevidipine",
            "dosing": {
              "instructions": "Start 1-2 mg/hr IV; titrate by doubling q90sec initially; max 32 mg/hr",
              "orderSentence": null
            },
            "contraindications": "Soy/egg allergy, severe aortic stenosis, lipid disorders",
            "monitoring": "Continuous BP; rapid onset; short half-life",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Blood pressure management (post-tPA)",
            "dosing": {
              "instructions": "Labetalol 10-20 mg IV q10min, nicardipine 5-15 mg/hr IV, or clevidipine 1-32 mg/hr IV",
              "orderSentence": null
            },
            "contraindications": "Asthma (labetalol); soy/egg allergy (clevidipine)",
            "monitoring": "Continuous BP; target BP <180/105 for 24 hours post-tPA",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Mechanical thrombectomy",
            "dosing": {
              "instructions": "Endovascular clot retrieval; within 6 hours for anterior LVO; up to 24 hours with favorable perfusion imaging",
              "orderSentence": null
            },
            "contraindications": "Large completed infarct (ASPECTS <6), poor baseline function (mRS >2), no LVO",
            "monitoring": "Post-procedure: BP per protocol, groin site checks, neuro checks q1h",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Acute Supportive Care": [
          {
            "item": "NPO status",
            "indication": "All acute stroke until swallow evaluation",
            "dosing": {
              "instructions": "NPO until formal swallow screen passed",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Aspiration risk",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "IV fluids (isotonic) - Normal saline",
            "indication": "Volume resuscitation; avoid hypotension",
            "dosing": {
              "instructions": "0.9% NaCl; avoid dextrose-containing fluids (hyperglycemia worsens outcomes)",
              "orderSentence": null
            },
            "contraindications": "Volume overload",
            "monitoring": "I/O, daily weights",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Glucose management - Insulin",
            "indication": "Hyperglycemia in acute stroke",
            "dosing": {
              "instructions": "Sliding scale or infusion; target glucose 140-180 mg/dL",
              "orderSentence": null
            },
            "contraindications": "Avoid hypoglycemia (<60)",
            "monitoring": "Glucose q1-6h depending on regimen",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis - Intermittent pneumatic compression",
            "indication": "All immobile patients",
            "dosing": {
              "instructions": "Apply to both legs",
              "orderSentence": null
            },
            "contraindications": "Active DVT",
            "monitoring": "Skin checks",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "DVT prophylaxis - Enoxaparin",
            "indication": "After 24-48 hours if no hemorrhagic transformation and not on anticoagulation",
            "dosing": {
              "instructions": "40 mg SC daily; reduce to 30 mg if CrCl <30",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, HIT, hemorrhagic transformation",
            "monitoring": "Platelets; signs of bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "DVT prophylaxis - Heparin (unfractionated)",
            "indication": "Alternative to enoxaparin if CrCl <30",
            "dosing": {
              "instructions": "5000 units SC q8-12h",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, HIT, hemorrhagic transformation",
            "monitoring": "Platelets; signs of bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Fever management - Acetaminophen",
            "indication": "Target normothermia; fever worsens outcomes",
            "dosing": {
              "instructions": "650-1000 mg PO/PR q4-6h PRN temp >38C; max 4g/day",
              "orderSentence": null
            },
            "contraindications": "Hepatic impairment",
            "monitoring": "Temperature",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Head of bed positioning",
            "indication": "Optimize perfusion vs aspiration risk",
            "dosing": {
              "instructions": "HOB flat to 15 degrees initially if no LVO treated; elevate to 30 degrees if large infarct or aspiration risk",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Neuro exam",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Supplemental oxygen",
            "indication": "Hypoxia",
            "dosing": {
              "instructions": "Titrate to SpO2 >94%; avoid routine oxygen in non-hypoxic patients",
              "orderSentence": null
            },
            "contraindications": "None",
            "monitoring": "Continuous SpO2",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          }
        ],
        "Secondary Prevention (Initiate During Hospitalization)": [
          {
            "item": "Aspirin",
            "indication": "Non-cardioembolic stroke; first-line antiplatelet",
            "dosing": {
              "instructions": "Loading: 325 mg (after tPA, wait 24h and confirm no ICH on CT); Maintenance: 81-325 mg daily",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, aspirin allergy, concurrent anticoagulation",
            "monitoring": "Bleeding signs",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Clopidogrel",
            "indication": "Aspirin intolerance; or DAPT (see below)",
            "dosing": {
              "instructions": "Loading: 300-600 mg; Maintenance: 75 mg daily",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, severe hepatic impairment",
            "monitoring": "Bleeding, bruising",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dual antiplatelet therapy (DAPT) - Aspirin + Clopidogrel",
            "indication": "Minor stroke (NIHSS ≤3) or high-risk TIA within 24 hours; continue 21 days then single agent",
            "dosing": {
              "instructions": "Aspirin 81 mg + Clopidogrel 75 mg daily x 21 days; preceded by loading doses",
              "orderSentence": null
            },
            "contraindications": "Major stroke, high bleeding risk, planned surgery",
            "monitoring": "Bleeding; discontinue one agent at day 21",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dual antiplatelet therapy (DAPT) - Aspirin + Ticagrelor",
            "indication": "Alternative DAPT regimen (THALES trial)",
            "dosing": {
              "instructions": "Aspirin 81 mg + Ticagrelor 90 mg BID x 30 days",
              "orderSentence": null
            },
            "contraindications": "Major stroke, high bleeding risk, planned surgery; avoid with strong CYP3A4 inhibitors",
            "monitoring": "Bleeding; dyspnea (common); discontinue one agent at day 30",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Atorvastatin",
            "indication": "All ischemic stroke; high-intensity statin",
            "dosing": {
              "instructions": "40-80 mg daily; start in hospital",
              "orderSentence": null
            },
            "contraindications": "Active liver disease, pregnancy",
            "monitoring": "LFTs at baseline; CK if myalgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rosuvastatin",
            "indication": "Alternative high-intensity statin",
            "dosing": {
              "instructions": "20-40 mg daily",
              "orderSentence": null
            },
            "contraindications": "Active liver disease, pregnancy; dose adjust for Asian patients, CKD",
            "monitoring": "LFTs at baseline; CK if myalgia",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Apixaban",
            "indication": "Cardioembolic stroke (AF); start after imaging confirms no hemorrhagic transformation",
            "dosing": {
              "instructions": "5 mg BID; reduce to 2.5 mg BID if 2 of: age ≥80, weight ≤60 kg, Cr ≥1.5",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment; delay 4-14 days post-stroke based on infarct size",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Rivaroxaban",
            "indication": "Alternative DOAC for AF",
            "dosing": {
              "instructions": "20 mg daily with dinner; 15 mg if CrCl 15-50",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment; delay 4-14 days post-stroke",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Dabigatran",
            "indication": "Alternative DOAC for AF",
            "dosing": {
              "instructions": "150 mg BID; 75 mg BID if CrCl 15-30",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment; GI upset common; delay 4-14 days post-stroke",
            "monitoring": "Renal function; bleeding; requires reversal agent availability",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Edoxaban",
            "indication": "Alternative DOAC for AF",
            "dosing": {
              "instructions": "60 mg daily; 30 mg if CrCl 15-50, weight ≤60 kg, or concurrent P-gp inhibitor",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, mechanical valve, severe hepatic impairment; delay 4-14 days post-stroke",
            "monitoring": "Renal function; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Warfarin",
            "indication": "Mechanical valve, antiphospholipid syndrome, DOAC contraindication",
            "dosing": {
              "instructions": "Start with DOAC or heparin bridge; target INR 2-3 (2.5-3.5 for mechanical mitral)",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, severe hepatic impairment; delay 4-14 days post-stroke",
            "monitoring": "INR weekly then monthly; bleeding",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Lisinopril",
            "indication": "Hypertension; target BP <130/80 after acute phase",
            "dosing": {
              "instructions": "Start 2.5-5 mg daily; titrate to 20-40 mg daily",
              "orderSentence": null
            },
            "contraindications": "Bilateral renal artery stenosis, angioedema history, pregnancy",
            "monitoring": "BP, K+, Cr",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Amlodipine",
            "indication": "Hypertension; add-on or alternative",
            "dosing": {
              "instructions": "Start 5 mg daily; max 10 mg daily",
              "orderSentence": null
            },
            "contraindications": "Severe aortic stenosis",
            "monitoring": "BP, peripheral edema",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Chlorthalidone",
            "indication": "Hypertension; add-on for volume-dependent HTN",
            "dosing": {
              "instructions": "12.5-25 mg daily",
              "orderSentence": null
            },
            "contraindications": "Sulfa allergy (relative), hypokalemia, gout",
            "monitoring": "K+, Na+, uric acid",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Complications Management": [
          {
            "item": "Mannitol",
            "indication": "Cerebral edema; increased ICP",
            "dosing": {
              "instructions": "0.5-1.5 g/kg IV over 20-30 min; may repeat q6h; serum osm goal <320",
              "orderSentence": null
            },
            "contraindications": "Hypovolemia, anuria",
            "monitoring": "Serum osm, Na+, renal function; Foley required",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 23.4%",
            "indication": "Severe cerebral edema; herniation",
            "dosing": {
              "instructions": "30 mL IV push via central line over 10-20 min",
              "orderSentence": null
            },
            "contraindications": "Severe hypernatremia (Na >160)",
            "monitoring": "Na q4-6h; target Na 145-155 for edema",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Hypertonic saline 3%",
            "indication": "Cerebral edema (less severe)",
            "dosing": {
              "instructions": "150-500 mL IV bolus or continuous infusion at 30-50 mL/hr",
              "orderSentence": null
            },
            "contraindications": "Severe hypernatremia (Na >160)",
            "monitoring": "Na q4-6h; target Na 145-155 for edema",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Decompressive craniectomy",
            "indication": "Malignant MCA infarction with edema; age <60",
            "dosing": {
              "instructions": "Surgical; within 48 hours of stroke onset",
              "orderSentence": null
            },
            "contraindications": "Poor pre-stroke function, extensive infarct, patient/family preference",
            "monitoring": "Post-op neuro checks, ICP if monitored",
            "ED": "-",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "URGENT"
          },
          {
            "item": "Levetiracetam",
            "indication": "Seizure prophylaxis not routinely recommended; use only if seizure occurs",
            "dosing": {
              "instructions": "500-1000 mg IV/PO BID; max 3000 mg/day",
              "orderSentence": null
            },
            "contraindications": "None significant",
            "monitoring": "Mood, behavior",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Ceftriaxone + Metronidazole",
            "indication": "Aspiration pneumonia",
            "dosing": {
              "instructions": "Ceftriaxone 1-2 g IV daily + Metronidazole 500 mg IV/PO q8h",
              "orderSentence": null
            },
            "contraindications": "Cephalosporin allergy, alcohol with metronidazole",
            "monitoring": "WBC, fever, respiratory status",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          }
        ],
        "Special Situations": [
          {
            "item": "Heparin infusion",
            "indication": "Cervical artery dissection (controversial), bridge to warfarin",
            "dosing": {
              "instructions": "80 units/kg bolus, then 18 units/kg/hr; titrate to PTT 60-80",
              "orderSentence": null
            },
            "contraindications": "Active bleeding, large infarct, hemorrhagic transformation",
            "monitoring": "PTT q6h until therapeutic, then q12-24h",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "PFO closure (device)",
            "indication": "Cryptogenic stroke with high-risk PFO (large shunt, atrial septal aneurysm); age <60",
            "dosing": {
              "instructions": "Interventional procedure; typically after stroke recovery",
              "orderSentence": null
            },
            "contraindications": "Active infection, other stroke etiology identified",
            "monitoring": "Post-procedure: antiplatelet therapy, bubble study follow-up",
            "ED": "-",
            "HOSP": "-",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid endarterectomy (CEA)",
            "indication": "Symptomatic carotid stenosis 70-99%; some benefit 50-69%",
            "dosing": {
              "instructions": "Surgical; timing 2-14 days post-stroke optimal",
              "orderSentence": null
            },
            "contraindications": "Unstable medical condition, near-complete occlusion",
            "monitoring": "Post-op: BP control, neuro checks",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Carotid artery stenting (CAS)",
            "indication": "Alternative to CEA; high surgical risk patients",
            "dosing": {
              "instructions": "Interventional procedure",
              "orderSentence": null
            },
            "contraindications": "Unstable medical condition, near-complete occlusion; unfavorable anatomy",
            "monitoring": "Post-procedure: DAPT x 30 days minimum",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ]
      },
      "Other Recommendations": {
        "Referrals & Consults": [
          {
            "item": "Stroke neurology consult",
            "indication": "All acute ischemic stroke",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "STAT"
          },
          {
            "item": "Interventional neuroradiology/neuroendovascular",
            "indication": "LVO identified; thrombectomy candidate",
            "ED": "STAT",
            "HOSP": "STAT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Neurosurgery consult",
            "indication": "Malignant edema; decompressive craniectomy candidate",
            "ED": "URGENT",
            "HOSP": "URGENT",
            "OPD": "-",
            "ICU": "STAT"
          },
          {
            "item": "Cardiology consult",
            "indication": "AF management, PFO evaluation, cardiac source workup",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Vascular surgery consult",
            "indication": "Symptomatic carotid stenosis; CEA candidate",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Speech-language pathology",
            "indication": "Swallow evaluation; aphasia therapy",
            "ED": "-",
            "HOSP": "STAT",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Physical therapy",
            "indication": "Mobility, gait, balance",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Occupational therapy",
            "indication": "ADLs, upper extremity function",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "ROUTINE"
          },
          {
            "item": "Rehabilitation medicine (PM&R)",
            "indication": "Inpatient rehabilitation placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Social work",
            "indication": "Discharge planning, community resources",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Case management",
            "indication": "Insurance authorization, rehab placement",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Palliative care",
            "indication": "Large stroke with poor prognosis; goals of care",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "-",
            "ICU": "ROUTINE"
          },
          {
            "item": "Smoking cessation counseling",
            "indication": "All smokers",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          },
          {
            "item": "Nutrition/Dietitian",
            "indication": "Dysphagia diet, heart-healthy diet education",
            "ED": "-",
            "HOSP": "ROUTINE",
            "OPD": "ROUTINE",
            "ICU": "-"
          }
        ],
        "Patient Instructions": [
          {
            "item": "Call 911 immediately if new or worsening weakness, numbness, vision changes, speech difficulty, or severe headache",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Know stroke warning signs: F.A.S.T. (Face drooping, Arm weakness, Speech difficulty, Time to call 911)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Take all prescribed medications as directed; do not stop antiplatelet or anticoagulant without physician guidance",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Attend all follow-up appointments (neurology, cardiology, primary care)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "No driving until cleared by physician (typically minimum 2-4 weeks; varies by state law and deficit severity)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Report any bleeding (blood in stool, urine, gums, excessive bruising) while on blood thinners",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Check blood pressure at home daily if hypertensive; keep log for follow-up visits",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Monitor blood glucose if diabetic; maintain good glycemic control",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Follow swallow precautions if dysphagia present (diet modification, positioning, supervision)",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Use fall precautions: clear pathways, use assistive devices as prescribed, adequate lighting",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          }
        ],
        "Lifestyle & Prevention": [
          {
            "item": "Smoking cessation (most important modifiable risk factor)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Blood pressure control: target <130/80 mmHg",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "LDL cholesterol target <70 mg/dL (or 50% reduction) with high-intensity statin",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Diabetes management: HbA1c target <7%",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Limit alcohol: ≤1 drink/day women, ≤2 drinks/day men; abstinence if alcohol-related stroke",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Heart-healthy diet: Mediterranean or DASH diet",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Regular aerobic exercise: 40 min moderate-intensity 3-4 days/week when able",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Weight management: BMI target 18.5-24.9",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Sleep apnea screening and treatment if indicated",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Avoid illicit drugs (cocaine, amphetamines)",
            "ED": "✓",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Hormone replacement therapy: avoid or use caution",
            "ED": "-",
            "HOSP": "✓",
            "OPD": "✓"
          },
          {
            "item": "Stress management",
            "ED": "-",
            "HOSP": "-",
            "OPD": "✓"
          }
        ]
      }
    },
    "differential": [
      {
        "diagnosis": "Hypoglycemia",
        "features": "Rapid response to glucose; often diabetic on insulin/sulfonylureas",
        "tests": "Point-of-care glucose; resolves with correction"
      },
      {
        "diagnosis": "Seizure with Todd's paralysis",
        "features": "History of seizure; gradual resolution over hours; post-ictal confusion",
        "tests": "EEG; witnessed seizure; gradual resolution"
      },
      {
        "diagnosis": "Complex migraine with aura",
        "features": "Headache (usually); positive symptoms (scintillating scotoma); history of similar; <60 min",
        "tests": "Clinical history; normal imaging; resolves"
      },
      {
        "diagnosis": "Intracranial hemorrhage",
        "features": "Sudden severe headache; rapid progression; may have anticoagulation history",
        "tests": "CT head shows hemorrhage"
      },
      {
        "diagnosis": "Brain tumor",
        "features": "Gradual onset; headache; seizures; may have mass effect",
        "tests": "MRI brain shows mass lesion"
      },
      {
        "diagnosis": "Subdural hematoma",
        "features": "History of trauma (may be minor); elderly; anticoagulation",
        "tests": "CT shows crescent-shaped collection"
      },
      {
        "diagnosis": "Encephalitis",
        "features": "Fever; altered mental status; seizures; behavioral changes",
        "tests": "MRI (temporal lobe); LP; CSF PCR"
      },
      {
        "diagnosis": "Multiple sclerosis (acute relapse)",
        "features": "Younger patient; prior episodes; MRI pattern (periventricular, Dawson fingers)",
        "tests": "MRI brain/spine; LP (oligoclonal bands)"
      },
      {
        "diagnosis": "Conversion disorder/functional neurological disorder",
        "features": "Inconsistent exam; positive functional signs (Hoover, give-way weakness)",
        "tests": "Clinical; normal imaging; psychiatric history"
      },
      {
        "diagnosis": "Wernicke encephalopathy",
        "features": "Ataxia, ophthalmoplegia, confusion; alcohol/malnutrition history",
        "tests": "Clinical; MRI (mammillary bodies); thiamine response"
      },
      {
        "diagnosis": "Hypertensive encephalopathy",
        "features": "Severely elevated BP; headache; confusion; PRES pattern on MRI",
        "tests": "MRI (PRES); BP reduction reverses symptoms"
      },
      {
        "diagnosis": "Cerebral venous sinus thrombosis",
        "features": "Headache; may have hypercoagulable state or OCP use; hemorrhagic infarcts",
        "tests": "CT/MR venography; D-dimer"
      },
      {
        "diagnosis": "Hyponatremia",
        "features": "Confusion, seizures; recent medication change; SIADH",
        "tests": "BMP shows low sodium"
      },
      {
        "diagnosis": "Hepatic encephalopathy",
        "features": "Liver disease; asterixis; confusion",
        "tests": "Ammonia; LFTs; history"
      },
      {
        "diagnosis": "Drug intoxication",
        "features": "History of substance use; pupils; toxidrome",
        "tests": "Urine drug screen"
      }
    ],
    "evidence": [
      {
        "recommendation": "IV alteplase within 4.5 hours improves outcomes",
        "evidenceLevel": "Class I, Level A",
        "source": "[NINDS, ECASS III](https://pubmed.ncbi.nlm.nih.gov/7477192/)"
      },
      {
        "recommendation": "Tenecteplase non-inferior to alteplase",
        "evidenceLevel": "Class I, Level B",
        "source": "[AcT Trial, Menon et al. Lancet 2022](https://pubmed.ncbi.nlm.nih.gov/35779553/)"
      },
      {
        "recommendation": "Mechanical thrombectomy for LVO within 6 hours",
        "evidenceLevel": "Class I, Level A",
        "source": "[MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT](https://pubmed.ncbi.nlm.nih.gov/25517348/)"
      },
      {
        "recommendation": "Thrombectomy up to 24 hours with favorable imaging",
        "evidenceLevel": "Class I, Level A",
        "source": "[DAWN](https://pubmed.ncbi.nlm.nih.gov/29129157/); [DEFUSE 3](https://pubmed.ncbi.nlm.nih.gov/29364767/)"
      },
      {
        "recommendation": "DAPT (aspirin + clopidogrel) for minor stroke/high-risk TIA x 21 days",
        "evidenceLevel": "Class I, Level A",
        "source": "[CHANCE](https://pubmed.ncbi.nlm.nih.gov/23803136/); [POINT](https://pubmed.ncbi.nlm.nih.gov/29766750/)"
      },
      {
        "recommendation": "High-intensity statin therapy",
        "evidenceLevel": "Class I, Level A",
        "source": "[SPARCL](https://pubmed.ncbi.nlm.nih.gov/16899775/); AHA/ASA Guidelines"
      },
      {
        "recommendation": "Anticoagulation for AF-related stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Blood pressure management post-stroke",
        "evidenceLevel": "Class I, Level B",
        "source": "[AHA/ASA Guidelines 2021](https://pubmed.ncbi.nlm.nih.gov/34024117/)"
      },
      {
        "recommendation": "Early mobilization",
        "evidenceLevel": "Class III (Harm), Level A",
        "source": "[AVERT Trial](https://pubmed.ncbi.nlm.nih.gov/25892679/) - very early mobilization harmful"
      },
      {
        "recommendation": "Decompressive craniectomy for malignant MCA stroke",
        "evidenceLevel": "Class I, Level A",
        "source": "[DECIMAL, DESTINY, HAMLET pooled analysis](https://pubmed.ncbi.nlm.nih.gov/17303527/)"
      },
      {
        "recommendation": "PFO closure for cryptogenic stroke",
        "evidenceLevel": "Class I, Level B",
        "source": "[CLOSE](https://pubmed.ncbi.nlm.nih.gov/28902580/); [RESPECT](https://pubmed.ncbi.nlm.nih.gov/28885996/); [DEFENSE-PFO](https://pubmed.ncbi.nlm.nih.gov/29544871/)"
      },
      {
        "recommendation": "Carotid endarterectomy for symptomatic stenosis ≥70%",
        "evidenceLevel": "Class I, Level A",
        "source": "[NASCET](https://pubmed.ncbi.nlm.nih.gov/1852179/); [ECST](https://pubmed.ncbi.nlm.nih.gov/1674060/)"
      },
      {
        "recommendation": "Intensive glucose control (avoid hypoglycemia)",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      },
      {
        "recommendation": "Fever treatment",
        "evidenceLevel": "Class I, Level C",
        "source": "AHA/ASA Guidelines"
      }
    ],
    "monitoring": [
      {
        "item": "NIHSS (National Institutes of Health Stroke Scale)",
        "frequency": "Q1h x 24h, then q4h x 48h, then q shift",
        "action": "If worsening ≥4 points: emergent CT, consider hemorrhage or extension",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Blood pressure",
        "frequency": "Q15min x 2h post-tPA, then q30min x 6h, then q1h x 16h; q4h after",
        "action": "Treat per protocol; labetalol, nicardipine",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Glucose",
        "frequency": "Q6h; q1h if on insulin infusion",
        "action": "Insulin adjustment",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "Temperature",
        "frequency": "Q4h",
        "action": "Acetaminophen; cooling; infection workup if fever",
        "ED": "STAT",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Oxygen saturation",
        "frequency": "Continuous if on supplemental O2",
        "action": "Oxygen titration; evaluate for aspiration, PE",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Neurological examination",
        "frequency": "Q1h x 24h, then per protocol",
        "action": "If worsening: emergent imaging",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "ROUTINE",
        "ICU": "STAT"
      },
      {
        "item": "INR (if on warfarin)",
        "frequency": "Daily until therapeutic",
        "action": "Warfarin dose adjustment",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Renal function (Cr, BUN)",
        "frequency": "Daily during hospitalization; baseline for DOACs",
        "action": "DOAC dose adjustment; avoid nephrotoxins",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "ROUTINE"
      },
      {
        "item": "Lipid panel",
        "frequency": "Fasting, within 24-48h",
        "action": "Statin intensification",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "HbA1c",
        "frequency": "Once during hospitalization",
        "action": "Diabetes medication optimization",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "ROUTINE",
        "ICU": "-"
      },
      {
        "item": "Swallow evaluation",
        "frequency": "Before any oral intake",
        "action": "NPO; modified diet; SLP consult",
        "ED": "-",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Continuous cardiac telemetry",
        "frequency": "Minimum 24-72 hours",
        "action": "Anticoagulation if AF detected",
        "ED": "STAT",
        "HOSP": "STAT",
        "OPD": "-",
        "ICU": "STAT"
      },
      {
        "item": "Repeat CT head",
        "frequency": "24 hours post-tPA; or if neurological decline",
        "action": "If hemorrhage: reverse anticoagulation, neurosurgery consult",
        "ED": "-",
        "HOSP": "ROUTINE",
        "OPD": "-",
        "ICU": "ROUTINE"
      }
    ],
    "disposition": [
      {
        "disposition": "**Discharge home**",
        "criteria": "Minor stroke or TIA; able to ambulate safely or with minimal assistance; swallow intact; stable on oral medications; adequate home support; follow-up arranged within 1-2 weeks; compliant with secondary prevention"
      },
      {
        "disposition": "**Admit to stroke unit/floor**",
        "criteria": "Most acute ischemic strokes; requires monitoring, workup, rehabilitation assessment; stable vital signs; no respiratory compromise"
      },
      {
        "disposition": "**Admit to ICU**",
        "criteria": "Received tPA or thrombectomy (24h monitoring); large vessel occlusion; declining neurological exam; respiratory compromise; malignant edema risk; BP requiring IV infusion; arrhythmia requiring intervention"
      },
      {
        "disposition": "**Inpatient rehabilitation**",
        "criteria": "Significant functional deficits; able to participate in 3 hours therapy/day; medically stable; expected to benefit"
      },
      {
        "disposition": "**Skilled nursing facility**",
        "criteria": "Functional deficits; unable to tolerate intensive rehabilitation; needs skilled nursing care"
      },
      {
        "disposition": "**Long-term acute care (LTAC)**",
        "criteria": "Prolonged ventilator dependence; complex medical needs"
      },
      {
        "disposition": "**Transfer to comprehensive stroke center**",
        "criteria": "LVO needing thrombectomy not available locally; neurosurgical intervention needed; complex case"
      }
    ]
  }
}